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3 Abbrevations 
 
ACT Artemisinin-based combination therapy 
AD Anno Domini 
ARDS Acute respiratory distress syndrome 
BC Before Christ 
bp base pair 
CDC Centers for Disease Control and Prevention 
CHTs Chittagong Hill Tracts 
cox1 cytochrome c oxidase 1  
cox3 cytochrome c oxidase 3  
Csp circumsporozoite protein 
Cytb cytochrome b 
DNA Deoxyribonucleic acid 
e.g. exempli gratia 
ELISA enzyme-linked immunosorbant assay 
HRP2 histidin rich protein 2 
ICDDR,B International Centre for Diarrhoeal Disease 
Research, Bangladesh 
kb kilobase 
LSU rRNA large subunit ribosomal RNA 
MARIB Malaria Research Initiative Bandarban 
MSP-1 Merozoite surface protein-1 
NGO Non-governmental organization 
PCR polymerase chain reaction 
pLDH parasite lactate dehydrogenase 
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PoRBP2 Plasmodium ovale reticulocyte binding pro-
tein 2 
PoTRA Plasmodium ovale tryptophan rich antigen 
gene 
RDT rapid diagnostic test 
RPMI Roswell Park Memorial Institute Medium 
SSU rRNA small subunit ribosomal RNA 
UNDP United Nations Development Programme 
WHO World Health Organization 
 
 8 
4  Introduction 
 
4.1 Malaria 
 
Malaria is a mosquito-borne disease caused by protozoan parasites of the genus Plasmo-
dium. More than 3.2 billion people worldwide live in risk of infections with malaria para-
sites (Fig. 1). 1.2 billion thereof live in areas with high malaria risk (WHO 2010c). It is 
estimated that the number of cases of malaria rose from 233 million in 2000 to 244 million 
in 2005 but decreased to 225 million in 2009. The number of deaths due to malaria is esti-
mated to have  
decreased  from  985 000  in  2000  to  781 000  in  2009. The majority of those malaria 
cases occurred in Africa (> 13.2 million), followed by South-East Asia (> 2.7 million), 
Eastern Mediterranean regions (> 1 million), the Americas (561,000) and the Western Pa-
cific region (247,669) (WHO 2010c). 
 
 
 
Fig. 1: Estimated malaria incidences per 1,000 persons (Source: WHO 2008). 
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Traditionally four malaria parasites are recognized in human, but in the last years molecu-
lar epidemiological and phylogenetic studies added another two to a total of six species. 
The systematic status of those parasites is given below according to Adl et al. (2005). 
 
Domain: Eukaryota 
Kingdom: Chromalveolata ADL et al., 2005 
Superphylum: Alveolata CAVALIER-SMITH, 1991 
Phylum: Apicomplexa LEVINE, 1980 emend. ADL et al. 2005 
Class: Aconoidasida MEHLHORN, PETERS and HABERKORN, 1980 
Order: Haemospororida DANILEWSKY, 1885 
Genus: Plasmodium MARCHIAFAVA AND CELLI, 1885    
Species:   
Plasmodium falciparum 
Plasmodium vivax 
Plasmodium malariae 
Plasmodium ovale curtisi 
Plasmodium ovale wallikeri 
Plasmodium knowlesi 
 
 
4.2 History of malaria 
 
The genus Plasmodium is a product of thousands of years of evolution, which still is pro-
ceeding. Species of this genus are known in almost all strictly terrestrial vertebrates pos-
sessing more or less strict host specificity (Coatney et al. 1971). 
Diseases with malaria-like symptoms were first described by ancient Chinese and Egyp-
tians (hieroglyphs), but it is not definitely clear if those were caused by malaria parasites 
(Warrel and Giles 2002). In ancient Greece (about 400 BC) Hippocrates was the first mala-
rologist, describing various clinical symptoms like fevers (Coatney et al. 1971). About 30 
AD Aulus Cornelius Celsus, a Roman encyclopedist, described two different kinds of ter-
tian fever in “De Medicina”. Galen of Pergamon documented (probably malaria related) 
jaundice and seasonal fever in the summer.  
In the 17th century a bitter extract of the bark of the chinchona tree, used by the indigenous 
Peruvian population against malaria-like fevers, was introduced to Europe by the Jesuits. 
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Chinchona bark was first described in Heyden’s “Discours et Aris sur les fluis de ventre” 
in Antwerp in 1643 (Coatney et al. 1971). In 1775 Torti documented that cinchona bark is 
not effective against all kind of fever diseases. Giovanni Maria Lancisi described several 
malaria-like epidemics in Italy and found black pigments in human spleens and brains. 
Furthermore, he came up with the connection between insects and malaria. The importance 
of malaria and its therapy increased during the years of colonialization. 
In 1831 Boyle introduced the swamp theory and named the disease mal’aria (bad air) and 
paludiena. Malaria was also called ague or marsh fever because of its emergence in areas 
close to marshland or swamps (Reiter 2004). In 1848 Meckel described the occurring of 
black pigments in protoplasmic masses but it took until 1879 when Afanasiev mentioned 
that these bodies are causing diseases.  
In 1880 Charles Louis Alphonse Laveran was the first scientist who described P. falcipa-
rum gametocytes in malaria patients, but most scientists did not pay attention because of 
the belief that malaria is caused by bacteria (Warrel and Gilles 2002). In 1897 Mac Callum 
observed fertilization in bird malaria and later in P. falciparum at the John’s Hopkins Uni-
versity in Baltimore (Coatney et al. 1971). Ronald Ross documented in 1896 the exflagela-
tion of P. falciparum in the stomach of Anopheles mosquitoes, and later described the 
sporogonic cycle of a bird malaria parasite P. relictum. Further on, Theobald Smith men-
tioned mosquitoes as vectors of malaria (Russell 1955). Amico Bignami (1898) infected 
volunteers with P. falciparum, and in 1899 Grassi, Bignami and Bastianelli were able to 
complete the cycle of P. falciparum, and Bastianelli and Bignami those of P. vivax. Those 
results were summarized by Grassi in 1900. 
The genus Plasmodium was first mentioned by Marchiafava and Celli in 1885. However, 
the systematics in those times were chaotic, and so several names were used for this genus: 
Haemamoeba, Oscillaria, Laverania and Haemomonas (Coatney et al. 1971). P. malariae 
was named by Charles Louis Alphonse Laveran in 1881. Grassi and Feletti (1890) de-
scribed P. vivax and named this parasite Haemamoeba vivax. Plasmodium falciparum was 
named Haematozoon falciparum by Welch in 1897.  
At the beginning of the 20th century 3 Plasmodium parasites were recognized to cause ma-
laria in human. First vector control trials were started in Havana/Cuba by Gorgas in 1900 
and continued at the building of the Panama Canal in 1907, which enabled the completion 
of this channel. Between the 1930’s and 1940’s the first insecticides were introduced. In 
these decades primate malaria studies started, and Shortt discovered pre-erythrocytic stages 
of Plasmodium parasites in 1948. Furthermore, several scientists discovered numerous 
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malaria parasites in monkeys and the first evidence of the zoonotic impact of simian ma-
laria parasites emerged (Coatney et al. 1971).  
It took until 1976 when Willam Trager and James Jensen established the cultivation of P. 
falciparum (Trager and Jensen 1976). Modifications of this technique are still in use and 
are essential for the in vitro diagnosis of drug resistances and sensitivity assays in P. falci-
parum and other malaria parasites. 
 
 
4.3 Life cycle of Plasmodium sp. 
4.3.1 Asexual life cycle 
With the mosquito drawing a blood meal spindle shaped sporozoites are introduced into 
the body within the saliva. Some sporozoites are destroyed by the host’s macrophages; 
others enter the lymphatic system, and still others the blood vessels of its intermediate host 
(Vaughan et al. 2008; Yamauchi et al. 2007). Within 70 min the sporozoites reach the liver 
via the blood stream and invade hepatocytes (Cerami et al. 1992). At the preerythrocytic 
schizogony in the liver each sporozoite develops into a trophozoite and multiplies to exo-
erytrhrocyctic schizonts (Fig. 2). These schizonts grow to a size of 40-60 µM after 5-7 
days with up to 50,000 daughter cells. The outer surface is increasing. There the nuclei 
attach to a portion of plasma and detach as merozoite from the schizont (Cerami et al. 
1992; Warrel and Giles 2002; Döngens 1988). Most Plasmodium species have the ten-
dency to repeat the liver schizogeny - with the exception of P. falciparum (blood schizog-
ony).  
The prepatence period ends with the start of the erythrocytic schizogony which needs 24-
72 hours. Haemozoin results at the degradation of haemoglobin and forms the malaria 
pigment (Dorn et al. 1955). The merozoites invade erythrocytes of special stages. Each 
Plasmodium species has its own preferences: e.g. P. malariae prefers older erythrocytes, 
whereas P. vivax invades retikulocytes. Within the red blood cells merozoites develop into 
ring forms (young trophozoites), trophozoites, pre-schizonts and schizonts. Each mature 
schizont inhabits 8-24 merozoites which are released when the erythrocyte ruptures. At 
most Plasmodium species the erythrocytic schizogony is synchronized and all infected red 
blood cells rupture within a time frame of 1-3 hours. Fever attacks are caused due to the 
host’s immune response to this synchronized system (Warrel and Giles 2002). The mero-
zoites invade new erythrocytes and the erythrocytic cycle restarts. To slip through re-
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sponses of the immune system this synchronization system is needed, and the invasion of 
new erythrocytes needs 20 seconds only (Döngens 1988). Merozoites are not able to in-
vade liver cells and are thus only able to restart the erythrocytic schizogony. A host can 
inhibit up to 1013 parasites (Greenwood et al. 2008). 
After a species-specific time frame (e.g. 1-3 weeks at P. falciparum) certain parasites start 
differentiation at blood schizogony and develop into extra-cellular, non-pathogenic game-
tocytes. P. vivax develops gametocytes soon after the release of the liver schizogony, 
whereas P. falciparum has its gametocyte peak about one week after the asexual erythro-
cytic peak (Pukrittayakamee et al. 2008, Miller et al. 2002). Gametocytes can be found in 
the peripheral blood from weeks up to months. The proportion between the female macro-
gametocytes and the male microgametocytes is 4:1.  
 
4.3.2 Sexual reproduction (Sporogony) 
At blood meal the definitive host, the Anopheles mosquito, intakes macro- and microgame-
tocytes. They find their way to the gut of the mosquito host where sporogony is initiated. 
Mikrogametocytes exflagellate to haploid male gametes and fuse with female gametes into 
diploid zygotes. Within 18 hours they develop into ookinets with a size of 18x3 µM 
(Döngens 1998). Until this development stage sporogony can also occur in inappropriate 
hosts like species of the genus Culex.  
The ookinet changes its shape to a round form in cells of the midgut. Parasites grow to 
oocysts within 10 days. Up to 1,000 active sporozoites are released at the rupture of the 
oocyst (Marsh and Makani 2004). Via the hemolymph they reach the salivary glands of the 
mosquito, invade, and reach a new intermediate host with the saliva at the next blood meal 
of the insect. Sporozoites can survive up to 50 days in the salivary glands. Mosquitoes of-
ten harbour a huge load of sporozoites and can so infect several intermediate hosts 
(Döngens 1988). Sporogony is correlated with the outside temperature and differs between 
different Plasmodium species. At temperatures below 20°C there is no sporogony at P. 
falciparum (Döngens 1988). However, mosquitoes benefit from infections with Plasmo-
dium and vice versa. Infected insects were observed to have a higher survival rate and an 
increased rate of blood feeding (Barillas-Mury and Kumar 2005; Ferguson and Read 
2004). 
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Fig. 2: Life cycle of Plasmodium sp. (Source: http://www.cdc.gov/malaria/about/biology/). 
 
4.4 Plasmodium falciparum (Welch, 1897) 
 
P. falciparum is known as the causative of Malaria tropica, which is the most dangerous 
form of human malaria with a high rate of complications and mortality. More than 90% of 
all malaria infections worldwide were caused by this pathogen in 2006 (WHO, 2008). P. 
falciparum is distributed in tropical and sub-tropical regions worldwide (Fig. 3) (Coatney 
1971). Especially in sub-Saharan Africa P. falciparum is the predominant malaria-causing 
species, if compared to other parts of the world. However, P. falciparum was used to be 
common in the South-Eastern USA, the Mediterranean region and the Balkans, but was 
eliminated with eradication programs, advances in health systems and better economic 
conditions (Coatney 1971, Wernsdorfer 2002). Its distribution is dependent of temperature 
and height. P. falciparum was found in Kenya, Bolivia and Tajikistan at 2,600 m (Polu-
mordvinov 1945, Hackett 1945, Garnham 1948). 
P. falciparum seems to be the evolutionary youngest species causing malaria in human 
because it causes a high rate of mortality and damage in its intermediate host, the human 
being (Coatney 1971).  
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Fig. 3: Estimated percentage of infections with P. falciparum in 2006 (Source: WHO, 2008). 
 
4.4.1 Morphological features 
The asexual cycle of P. falciparum takes 48 h at an imperfect synchronized erythrocytic 
schizogony (Döngens 1988). This parasite is common for multiple invasions of the eryth-
rocytes and high parasite densities (Shute 1956). In comparison to other human malaria 
parasites its young ring forms are smaller and infected host cells keep normal in size (Fig. 
4). Shortly after the hair-like ring forms Maurer’s dots are formed which are not really, but 
better visible after staining with special techniques (Coatney 1971). Trophozoites are rarely 
found at microscopic analysis, because of their tendency to stick on capillaries of inner 
organs or the brain. Mature schizonts contain 8 to more than 20 merozoites (usually 16) 
which are seldom seen in the peripheral blood (CDC). Adult gametocytes are sickle, ba-
nana-like or crescent shaped and appear about 10 days after the asexual forms in the pe-
ripheral blood. Macrogametocytes are longer than microgametocytes, with intensive blue 
colour and compact chromatin. Microgametocytes are sausage-shaped, reddish in colour 
and the chromatin is diffuse. 
The extraerythrocytic schizogony in the liver generates a single generation only. In com-
parison to other human malaria species mature schizonts are large in size and contain a 
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larger number of small merozoites (Shortt et al. 1951). The extraerythrocytic schizogony is 
rapid and takes 6 days only.   
 
Fig. 4: Erythrocytic schizogony of P. falciparum (Source: Coatney 1971). 
 
4.4.2 Pathogenesis 
Only a very short overview is given on the pathogenesis of P. falciparum. After an incuba-
tion period of 7-12 days initial symptoms appear. In general initial and uncomplicated ma-
laria symptoms are unspecific and multifaceted, like fever, headache, muscle ache, runny 
nose, fatigue, vomiting, nausea, chills, anaemia and splenomegaly. Fever caused by falci-
parum malaria is more often of the tertian than the quotidian type (Coatney 1971). Most 
cases in highly risky malaria endemic countries are uncomplicated, based on the patient’s 
semi-immunity status. In high-endemic areas severe malaria is primarily found in children 
and pregnant woman. However, if patients never had malaria before (e.g. in a low-endemic 
malaria area) infections can cause severe malaria in adults and children. According to the 
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WHO, severe malaria is present if one or more of the symptoms listed in Tab.1 and Tab.2 
are present. The most life-threatening complications in severe malaria are cerebral malaria, 
severe anaemia and respiratory distress.    
 
 
Tab. 1: Defining criteria for severe malaria (WHO 1990)  
Defining Criteria Finding 
Cerebral malaria (unrousable co-
ma) 
Unrousable coma not attributable to any other 
cause in a patient with falciparum malaria. Coma 
should persist at least 30 minutes after a general-
ized convulsion to make the distinction from 
transient post-ictal coma. 
Severe normocytic anemia Normocytic anemia with hematocrit < 15% or 
hemoglobin < 5 g/dL in the presence of para-
sitemia > 10,000 parasites per µL.  
Renal failure Urine output < 400 mL in 24 hours in adults, or 
12 mL per kg in children, failing to improve af-
ter rehydration, and with serum creatinine > 265 
µmol/L (3 mg/dL) 
Pulmonary edema, ARDS Clinical criterion 
Hypoglycemia Glucose < 2.2 mmol/L (< 40 mg/dL) 
Circulatory collapse, shock Hypotension (systolic blood pressure < 50 mm 
Hg in children 1-5 years old; < 70 mm Hg in 
adults)  
Spontaneous bleeding, DIC Spontaneous bleeding from gums, nose, GI tract 
or other sites, with laboratory evidence of DIC 
Repeated generalized seizures More than 2 observed seizures 
Acidemia or acidosis Arterial pH < 7.25, plasma bicarbonate < 15 
mmol/L 
Malarial haemoglobinuria Macroscopic haemoglobinuria 
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Tab. 2: Additional criteria for severe malaria (based on WHO 2000) 
Additional Criteria Finding 
Impaired consciousness but rousa-
ble 
Impaired consciousness less marked than un-
rousable coma, can localize a painful stimulus 
Prostration and extreme weakness Patient unable to sit or walk, with no other obvi-
ous neurological explanation 
Hyperparasitemia High parasite densities are associated with in-
creased risk of severe disease but is affected by 
the immune status (more than 5% parasitemia in 
non-immune patients) 
Jaundice Total bilirubin > 50 µmol/L (> 3 mg/dL) 
Hyperpyrexia Prolonged temperature > 40 °C 
Post-mortem evidence of severe 
malaria 
Neuropathologic evidence of venules and capil-
laries packed with erythrocytes containing ma-
larial parasites 
 
 
4.5 Plasmodium vivax (Grassi and Feletti, 1890) 
 
P. vivax is distributed in subtropical and tropical regions worldwide and the dominant hu-
man malaria species in temperate climates (Fig. 5). Approximately 130-145 million vivax 
malaria infections are estimated per year with 2.6 billion people living in risk regions 
(Baird 2007). P. vivax is discussed to be the most prevalent malaria parasite worldwide 
because of its high population density in Asia and its dominance in Middle and South 
America, where up to 70% of all malaria cases are caused by this parasite (Coatney 1971; 
Price et al. 2007; CDCb). Brumpt (1949) described the “benign tertian mystery” in West 
Africa because of the absence of vivax malaria. This is caused by the lack of the Duffy 
blood group antigen (Fy9) in 90% of the population in West-, Central-, and East Africa 
(Rosenberg 2007). P. vivax is dependent on this antigen to penetrate the erythrocyte. Like 
at P. falciparum this parasite’s distribution is limited by temperature because of its need of 
at least 15°C for sporogony. However, until the 20th century P. vivax was endemic in Mid-
dle Europe (e.g. Austria and Germany) (Wernsdorfer 2002; Köhler and Köhler 2008).  
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P. vivax is very closely related to P. simium, a simian malaria parasite in New World mon-
keys in Brazil. Molecular based phylogenetic analysis revealed that both are almost identi-
cal (Cornejo and Escalante 2007). Furthermore, P. vivax is closely related to P. cynomolgi, 
P. simiovale and even P. knowlesi and it is estimated that the origins of P. vivax were in 
Old World Monkeys (Macaca) before its switch to the human host (Cornejo and Escalante 
2007). 
 
 
 
Fig. 5: Global distribution of P. vivax (Source: Guerra et al. 2007). 
 
4.5.1 Morphological Features  
The erythrocytic schizogony takes 48 h. Merozoites have a preference to invade reticulo-
cytes. Young ring forms present a deep red nucleus of 1/3 in diameter of the erythrocyte 
(Fig. 6). Multiple invasions in one red blood cell are common (Coatney 1971). In mature 
trophozoites the cytoplasma is amoeboid in shape, Schueffner’s dots and the invaded 
erythrocyte possess twice the size of a normal red blood cell. Schizonts are large in size 
and contain 16 (12-24) merozoites (Coatney 1971, Döngens 1988). Soon after the start of 
blood schizogony gametocytes can be found in the host’s peripheral blood. Gametocytes 
are round and compact. Microgametocytes fill the whole erythrocyte, the nuclei are periph-
eral, and the plasma is diffuse. Macrogametocytes are bigger than a normal erythrocyte, 
and the cytoplasma is compact and eccentric (CDC) in shape.  
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Fig. 6: Asexual, erythrocytic life cycle of P. vivax  (Source: Coatney 1971). 
 
4.5.2 Pathogenesis 
The time of liver schizogony until the start of the blood schizogony (= prepatent time) 
takes 8-27 days and is dependent on the vivax variation type (Coatney 1971). P. vivax is 
known as a causative of tertian malaria with upcoming fever intervals every 48 hours, but 
initial fever can occur unspecific (Döngens 1988). Each fever peak emerges at the end of a 
synchronized blood schizogony round. At the rupture of the red blood cells not only mero-
zoites but also toxic antigens are released (e.g. lectinase is released and inhibits the cellular 
respiration within the mitochondria). Fever peaks may emerge every 24 hours (Malaria 
duplicata, Malaria quotidiana), if two parasite populations in different schizogony intervals 
are present (Döngens 1988).  
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Symptoms of vivax malaria are general weakness, headache, body pain, chills and fever up 
to 41°C. Fever occurs in malaria tertiana typically every 48 hours. Fever periods take 6-12 
hours and fever attacks recurr 12-15x (Coatney et al. 1971). Attacks of sweating are com-
mon when the fever decreases. Typically vivax malaria patients have no fever and feel well 
the day after a fever peak. Hepatosplenomegaly, anemia and bilirubinemia may be present.  
Not all sporozoites divide at the liver schizogony. Some do not divide or grow when enter-
ing the hepatocytes. The so called hypnozoites are dormant within the liver cell and cause 
relapses. Early relapses may occur within the first two months after a weathered vivax ma-
laria, whereas at late relapses may emerge up to 3 years after the primary infection.  
 
Normally the prognosis at vivax malaria is good. Complicated or severe vivax malaria 
cases are reported rarely and may cause retinal haemorrhage, ARDS, cerebral anaemia, 
renal failure and jaundice (Choi et al. 2004; Kocher et al. 2005).  
 
 
4.6 Plasmodium ovale (Stephens, 1922) 
 
4.6.1 History 
Because of its morphological similarity to the more prevalent malaria parasite P. vivax it is 
very difficult to date the first documentation of P. ovale. The first suspected case was re-
ported by Craig in 1900 in American soldiers who were based on the Philippines. They 
presented tertian fever and the parasites differed from P. vivax at microscopical analysis. In 
1914 Emin reported a variant form of P. vivax in pilgrims in Camaran at the Red Sea. He 
named this variant form P. vivax minuta, which was renamed as P. camaranese by Zie-
mann in 1915. Macfie and Ingram (1917) observed pronounced Schüffner’s strippling in 
parasites resembling quartan P. malariae infections in a child at the Gold Coast in Africa. 
In 1918 Stephens, who worked at the Liverpool School of Tropical Medicine, found ma-
laria parasites with fimbriated edges and an oval shape. In 1922 he named those parasites 
P. ovale but this discovery was not accepted by scientists for years (reviewed by Coatney 
1971; Collins and Jeffery 2005).  
The ancestral home of P. ovale is suggested to be tropical Africa. In 1949 Brumpt re-
viewed P. ovale cases documented by then and recognized that out of 105 cases only 14 
were diagnosed outside of Africa. Lysenko and Benjaev (1966) analyzed the distribution of 
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P. ovale and reported that outside Africa P. ovale can only be found on the Philippines and 
New Guinea and based the limited distribution on host-vector relationships, climate, vege-
tation, host susceptibility and the relation to simian malaria. The highest prevalence of P. 
ovale was examined in equatorial forests and savannahs in Africa. Similar vegetation and 
climate conditions can be found in the Western Pacific region (Coatney 1971).   
 
Several discussions came up if P. ovale is a zoonotic disease because of its rare occurrence 
in human (Coatney 1971). Since then tools for phylogenetic analyses changed from mor-
phological features to molecular based techniques (see Chapter xx), but the discussions of 
the zoonotic potential of P. ovale are still going on. Duval (2009) analyzed several con-
served gene regions of malaria parasites in chimpanzees (Pan troglodytes troglodytes) and 
was able to confirm the presence of P. ovale in those animal hosts.  
 
Different strains and variations of P. ovale have been known for decades, and P. ovale 
parasites were found in several countries in South-East Asia. Based on molecular tools two 
genetically distinct variations of P. ovale parasites were reported by several authors (de-
tailed in PCR chapter). Because of those dimorphic characters P. ovale was split in two 
species by the group around Sutherland in 2010, and named P. ovale curtisi (to honour 
Christopher F. Curtis) and P. ovale wallikeri (to honour David Walliker). The differentia-
tion into two species was based on the perfect segregation of five gene loci, the evidence of 
sympatric distribution in Africa and Myanmar, no recombination or mating of the two spe-
cies and differences in the cyt b gene (highly conserved region). Furthermore only minor 
differences in dhfr-ts sequences can be observed in P. falciparum, P. vivax and P. ma-
lariae, but in the case of P. ovale wallikeri and P. ovale curtisi those sequences are signifi-
cantly different. Cross mating experiments, which normally are essential for the determina-
tion of a new species, are almost impossible to perform in malaria parasites (Sutherland et 
al. 2010). The sympatric distribution of P. ovale wallikeri and P. ovale curtisi in Africa 
was further confirmed (Oguike et al. 2011). However, there is lack of knowledge about the 
sympatric distribution of those parasites in Asia.  
 
4.6.2 Distribution and Epidemiology 
P. ovale has been known for decades to have its main distribution area and to be relatively 
common in West African countries (like Nigeria, Ghana, Sierra Leone, Liberia and Gam-
bia). Its distribution spreads through Central Africa (where prevalences are less) to the East 
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African coast (e.g. Mozambique) (Coatney 1971). In Africa most cases were documented 
in children below the age of 8 years from savannah areas and less in forested regions 
(Lagan 1962; Mueller 2007). Microscopy based studies revealed a prevalence of up to 10% 
in West Africa (Garnham 1966). In Uganda a prevalence of 2.6% was reported in children 
between 1-4 years, compared to 0.7% in adults (> 20 years) (Onori 1967). However, it has 
to be mentioned that the focus of most studies was on children and the true prevalence may 
vary (Coatney 1971). 
 
Outside Africa the prevalence of P. ovale is normally low (3-5%). Before molecular diag-
nostic tools were introduced for the detection of malaria parasites, P. ovale was reported 
rarely on the Philippines, Papua New Guinea, Indonesian Islands (e.g. Flores) and some 
South-East Asian countries (Mueller et al. 2007). Until now this malaria causative has 
never been reported from South- or Central America.  
Infections with P. ovale are often asymptomatic and parasite densities are frequently very 
low. Mixed infections with other Plasmodium species can be observed frequently. There-
fore more sensitive techniques than microscopy are needed for epidemiological studies 
(Mueller et al. 2007). PCR-based epidemiological studies made it possible that P. ovale 
was reported in almost all South-East Asian countries, India and Yemen (e.g. Mueller et al. 
2007). In 1998 Zhou et al. observed a prevalence of 3.8% at the Thai-Myanmar border. In 
Myanmar P. ovale was observed several times with prevalence of up to 6.1% in Tanin-
tharyi Division (Kawamoto et al. 1999; Win et al. 2002). A low prevalence (< 4%) was 
reported from Cambodia, Thailand, Vietnam and Malaysia (Incardona et al. 2005; Puta-
porntip et al. 2009; Gleason et al. 1970; Kawamoto et al. 1996; Singh et al. 2004; Lim et 
al. 2010). Single cases were further observed in India and Sri Lanka (Wickremasinghe et 
al. 2008). Further reports of P. ovale were documented from China, the Philippines, Indo-
nesia, Thailand, Vietnam, Laos and Myanmar (reviewed in Win et al. 2002). 
 
Originally P. ovale was known as a human parasite only. In experimental studies P. ovale 
curtisi was successfully cultivated in intact and splenectomised chimpanzees (reviewed in 
Coatney 1971, Sutherland et al. 2010). By now chimpanzees were also reported as natural 
hosts of P. ovale (Duval et al. 2009).  
P. ovale has been reported to be transmitted by the following vectors: Anopheles albi-
manus, A. atroparvus, A. freeborni, A. maculates, A. quadrimaculatus, A. superpictus, A. 
stephensi, A. gambiae, A. funestus and A. dirus (Coatney 1971; Collins and Jeffrey 2005).  
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4.6.3 Life Cycle 
The asexual erythrocytic life cycle of P. ovale is of tertian kind and takes 48 hours. Mero-
zoites have a preference to invade reticulocytes (Collins and Jeffrey 2005). Multiple infec-
tions in one erythrocyte are common. Young ring forms have an eccentric, prominent, cir-
cular nucleus and sturdy cytoplasm surrounding a vacuole (Fig. 7). The parasitized eryth-
rocyte is enlarged. Early in blood schizogony Schüffner’s dots emerge which become more 
prominent in parasite growth. Overall Schüffnerization is more prominent as in P. vivax 
(Coatney 1971). During growth the amount of cytoplasm increases and the vacuole disap-
pears. Older trophozoites fill almost half of the host cell of oval shape and are fimbriated. 
Sometimes band-like forms can be observed. Pigmentation increases within schizogony. 
First dust-like grains are build, later compact beads and thereafter yellowish brown-stained 
patches. The cytoplasm is transparent and pale with masses of stippling. The nuclei are 
enlarged and 2-4 times of the size of those in a young ring. Schizonts possess 8 (6-14) 
merozoites. At relapses and at experimental infections in chimpanzees 12-16 merozoites 
can be observed in a heavily enlarged host cell (Coatney 1971, Collins and Jeffrey 2005).  
The sexual cycle of P. ovale takes around 49 hours. The cytoplasm of macrogametocytes 
stains blue, whereas the eccentric nuclei stain red. They fill the host erythrocyte com-
pletely. Prominent beads of pigments are present and Schüffner’s strippling is ring-shaped 
around the parasite. The cytoplasm of microgametocytes stains lighter blue and possesses 
pigment beads. The nucleus is very large and fills 50% of the parasite. The parasite is sur-
rounded with stippling.  
 
Liver schizogony takes about nine days, but some parasites stay dormant as hypnozoites in 
the liver and a second generation can occur 19 days after. According to Coatney (1971) it 
can be divided into three stages.  
1) The nuclear multiplication progresses rapidly with no evident merozoite formation 
2) Merozoites appear at the edges of the parasitized host cell and nucleus division 
takes place elsewhere in the parasite 
3) Schizonts mature completely and rupture 
 
Furthermore, liver schizogony differs from those of P. falciparum and P. vivax by a defi-
nite limiting periplast, tangential adjusted peripheral nuclear bars, and a minor hypertrophy 
of the host cell’s nucleus (Coatney 1971). 
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Fig. 7: Asexual, erythrocytic life cycle of P. ovale (Source: Coatney 1971). 
 
4.6.4 Pathogenesis 
In general infections with P. ovale are less severe than those with other human malaria 
parasites and cause mild clinical courses. Incubation period normally takes 11-18 days and 
fever may arise 17-18 days post infection (Coatney 1971). Nausea, resistant headache, 
chills and splenomegaly are common symptoms. Rigors are rarely observed. As at vivax 
malaria fever with temperatures up to 40.6 °C emerge every 34-61 hours (median = 49 
hours) for 6-10 hours. Peroxysms emerge 1-22 times at experimental studies with the 
“Donaldson” strain (mean = 10x). The fever decreases at the peaks of peroxysms (James et 
al. 1949). The maximal parasite density is lower than in infections with P. vivax and P. 
falciparum with 380-27,600 parasites/µl (reviewed in Collins and Jeffrey 2005). Parasites 
can be observed in the blood for 29-91 days, although clinical symptoms decrease after 
~17 days.  
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Relapses are common but asymptomatic in most cases. Around 17-255 days after the end 
of the first attack relapses can occur. Some authors reported delayed entries of first attacks 
at latent infections but it is suggested that those are relapses occurring 1.3-4 years post in-
fection (reviewed in Coatney 1971; Collins and Jeffrey 2005). 
 
Immunological studies revealed that semi-immunity to fresh infections with P. ovale can 
be observed in patients who had ovale malaria before. Semi-immunity was even reported 
between different strains like the Western Pacific “Donaldson”-strain and the West African 
“Liberian”-strain (Coatney 1971). However, no semi-immunity is present at fresh infec-
tions with other human Plasmodium species like P. falciparum, P. vivax and P. malariae. 
Garnham (1966) mentioned that the structure of antigens in P. ovale seems to be homoge-
nous.  
In West-Africa P. vivax is not present in Duffy-blood-group negative populations. How-
ever, P. ovale possess its highest prevalence worldwide in those areas and it is estimated 
that there is a negative interaction with P. vivax (Mueller et al. 2007).     
 
 
4.7 Plasmodium malariae (Grassi and Feletti 1890) 
 
The causative of malariae malaria, P. malariae, was first discovered in the blood of an Al-
gerian patient by Laveran in 1880. Laveran described 8 merozoites, a rosette formation, 
and a central body of pigments, which are typical morphological features of P. malariae 
(Coatney 1971). This cosmopolitan malaria parasite is distributed in sub-Saharan Africa, 
South-East Asia, western Pacific islands and in Central- and South America (Collins 
2007). P. malariae was formerly present in parts of Europe and the southern parts of the 
USA. The distribution of this pathogen is variable and spotty, and limited to a minimal 
temperature of at least 15°C, which is needed for sporogony within the mosquito host. Fur-
thermore P. malariae coincides with P. falciparum, and co-infections of both are very 
common (Collins 2007).  
Epidemiological studies documented high prevalence (15-30%) of P. malariae in Africa, 
Papua New Guinea and the Western Pacific, and infrequent observations (1-2%) in Asia, 
the Middle East, Central- and South America (Mueller et al. 2007).  
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P. malariae is assumed to be the oldest Plasmodium parasite in human, because of its high 
degree of adaption to its host. This parasite survives and stays longer in the blood than 
other malaria species and causes little discomfort. Opposing seasonal fluctuation between 
P. malariae and P. falciparum is known and Coatney (1971) described the situation of P. 
malariae as: “learned to wait in the wings”.    
For decades it is assumed that P. malariae possesses animal reservoirs in tropical regions. 
In Africa chimpanzees are parasitized by P. rhodhainii, which is morphologically very 
similar to P. malariae (Coatney 1971). In Asia no simian hosts of P. malariae are known. 
P. inui is a quartan simian parasite of Old World Monkeys in India and Malaysia, but is 
morphologically different from P. malariae. In South America a morphologically similar 
simian parasite of New World monkeys, P. brasilianum, is known. This parasite was not 
distinguishable from P. malariae at molecular phylogenetic analyses (Tazi et al. 2011, Es-
calante et al. 1995). It is estimated that P. brasilianum came from man to the monkeys, as 
vice versa (Coatney 1971). 
However, genetic and symptomatic differences within various strains of P. malariae are 
known. In China and at the Thai/Myanmar border phylogenetic analysis of P. malariae 
revealed differences within SSU rRNA sequences in variant forms of this parasite (Liu et 
al. 1998). 
 
4.7.1 Morphological features 
P. malariae sporozoites invade the liver fast within one hour post infectionem (Collins 
2007). Liver schizogony takes 15 days. Enlargement of host cells and its nucleus, periph-
eral and internal vacuoles, absence of cytomeres, large clefts, and plaques in mature liver 
schizonts are typical for P. malariae liver schizogony (Coatney 1971).  
P. malariae merozoites prefer to invade older red blood cells. Blood schizogony takes 72 
hours, and parasites grow more slowly in comparison to other human malaria parasites. 
Young ring forms of this parasite build no true ring (Fig. 8). Ring stages fill 1/4 - 1/3 of the 
erythrocyte. Sometimes a second chromatin is build. Mature trophozoites are sometimes 
(typical for P. malariae) ribbon-shaped – the so called band-forms. Pigments in 30-50 
granules are of dark-brown colour. The nuclei of schizonts build a rosette in the periphery 
of the cell. Mature schizonts are pigmented prominently and inhabit 8 (6-14) merozoites. 
After several weeks of blood infection gametocytes emerge. Those fill the non-enlarged 
erythrocyte, are round or oval in shape, and their pigment granula are scattered. Young 
gametocytes are morphologically very similar to asexual trophozoites. Mature macrogame-
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tocytes of P. malariae fill the red blood cell completely, have compact cytoplasma and a 
small, eccentric nucleus (Coatey 1971). Adult microgametocytes possess a light-bluish 
cytoplasma and a diffuse nucleus. Normally more microgametocytes than macrogameto-
cytes are present. 
 
Fig. 8: Morphological features of P. malariae (Source: Coatney 1971). 
 
4.7.2 Pathogenesis 
Depending on the P. malariae strain prepatent periods take 20-35 days (Döngens 1988). P. 
malariae is the causative of malariae malaria, which is relatively benign with a synchro-
nous 72 hour interval. Quartana duplicata occurs if 2 populations of schizonts are coexist-
ing, and present an interval of 2 days fever and 1 day free of fever (Döngens 1988).  
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Shortly after the segmentation of the schizonts fever starts and reaches its peak (up to 
40°C) at the rupture of the erythrocytes. Chills are typical within the increase of fever and 
take 13-195 minutes (mean = 53 min) (Coatney 1971). At P. malariae infections the para-
sitemia is lower (in comparison to P. falciparum or P. vivax) because of several factors like 
less merozoites in blood schizogony and longer erythrocytic schizogony cycle times. Para-
sitemias were reported to be between 1,648/µl and 49,680/µl (mean = 8,875/µl), and nor-
mally less than 0.25% of the erythrocytes are infected. The duration of an infection can be 
extremely long. Renal diseases are not uncommon and may end fatal (Collins 2007, Eiam-
Ong et al. 2003).  
 
Recrudescence is a well known phenomenon of P. malariae. This parasite does not relapse 
from persistent liver hypnozoites (Collins 2007). The origins of recrudescences are blood 
parasites in very low density (premunity). Recrudescences are discussed to be induced by 
stress. Latent chronic infections were reported with duration of more than 10 years. Be-
cause of those circumstances in some countries former quartana malaria patients are not 
allowed to donate blood (Döngens 1988). 
 
 
4.8 Plasmodium knowlesi Sinton and Mulligan, 1932 
 
Until very recently P. knowlesi was known as a simian parasite only. The distribution of 
this pathogen is strictly limited to South-East Asia because of those of both its intermediate 
and final hosts (Fig. 9). Until 1971 P. knowlesi was known to be endemic from peninsular 
Malaysia to the Philippines, and northwards up to Taiwan (Coatney 1971; Lambrecht et al. 
1961; Yokogawa et al. 1941). Meanwhile it was documented in several other South-East 
Asian countries (e.g. Myanmar, Thailand).  
The intermediate hosts of P. knowlesi are long tailed macaques (M. fascicularis), pig tailed 
macaques (M. nemestrina), and mitred leaf monkeys (Presbytis melalophos). In these natu-
ral hosts P. knowlesi cause mild infections with low parasite density (Cox-Singh and Singh 
2008a). This parasite can be experimentally inoculated into several other primates (e.g. 
rhesus monkeys). In rhesus monkeys infections often cause deadly full blown malaria. 
The vectors of P. knowlesi are mosquitoes of the Anopheles leucosphyrus group (e.g. A. 
latens, A. cracens) (Cox-Singh and Singh 2008a; Vythilingam et al. 2008).     
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Fig. 9: Distribution of P. knowlesi (Source: Cox-Singh and Singh 2008a) 
 
It might be that Franchini was the first one who described P. knowlesi in the blood of its 
simian host Silenus cynomolgus (Macaca fascicularis) in 1927. In 1931 Campbell and 
Napier found this parasite in M. fascicularis and were able to inoculate the pathogen to 
other macaques, of which one was a rhesus monkey developing fulminate malaria (Coat-
ney 1971). In 1932 Knowles and Das Gupta described the blood forms of P. knowlesi and 
inoculated it into human volunteers. P. knowlesi was named to honour Dr. R. Knowles. In 
the upcoming years discussions came up about the loss of virulence in continued man-to-
man transfer, and that previous infection with P. vivax lead to partial resistance against P. 
knowlesi in man (reviewed in Coatney 1971). P. knowlesi was further used therapeutically 
in human at general paresis and neurosyphilis. After first successes research was discon-
tinued because of the death of some participants (Kantele et al. 2011). Several variations of 
P. knowlesi are known, and some of those might be less pathogenic in rhesus monkeys. 
 
4.8.1 Morphology 
The quotidian asexual cycle of P. knowlesi needs 24 hours only. In man young ring forms 
reach large numbers in the circulation blood. The nucleus is spherical and prominent (Fig. 
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10). One or more accessory chromatins are common. Overall young ring forms resemble 
those of P. falciparum (Lee et al. 2009). Late trophozoits possess non-amoeboid shape and 
fill ½ or more of the red blood cell. Band forms may appear. From then on P. knowlesi 
resembles P. malariae (Lee et al. 2009). Pigmented dark grains are formed and the parasite 
becomes more compact. The nucleus increases in size and “Sinton and Mulligon’s stip-
pling” (stippling in erythrocyte) can be observed. Schizonts contain 10 (up to 16) mero-
zoites. Mature schizonts fill the parasitized red blood cell and pigment is visible as yellow-
ish-black masses, which sometimes form a single mass. Gametocytes grow more slowly 
than asexual forms and can be differentiated by colour (Coatney 1971). At macrogameto-
cytes the erythrocyte is enlarged, the cytoplasm is of blue and the eccentric nucleus of deep 
pink color. Scattered black pigment granules can be seen. In comparison microgamteocytes 
possess a pink-stained cytoplasm and a big, darker pink nucleus. Exoerythrocytic schizog-
ony takes place in parenchymal cells of the liver and takes less than 120 hours (Coatney 
1971). 
 
4.8.2 Pathogenesis 
After an incubation period of 9-12 days daily non-specific fever and chills emerge. Symp-
toms look like those of closely related P. vivax, but are more severe. Initial fever of 39°C is 
common, and fever peaks may reach up to 40-41°C appearing daily for about 10 days. 
Parasite densities are rarely over 100 parasites/10,000 RBCs, but in severe cases hyper-
parasitemia is common (Coatney et al. 1971). Because of the circumstances that the para-
site invades all stages of red blood cells and an asynchronous blood, schizogony para-
sitemias can be extremely high with up to 10-15% of infected erythrocytes in fatal cases. 
Furthermore pyrexia, tachypnea, tachycardia, myalgia, rigors, malaise, abdominal pain, 
breathlessness, and cough were reported (Daneshvar et al. 2009). Thrombocytopenia and 
mild hepatic dysfunction are common. In adults anaemia is rarely observed. However, in 
children very low haemoglobin levels and anaemia were observed in 69% of all knowlesi 
patients (Barber et al. 2011). 
Relapses (or recrudescences) can occur. Low levels of gametocytes can be found in human 
blood (Lee et al. 2009).  
In 7% of human infections the parasite causes severe knowlesi malaria with a mortality 
rate of 1.8% (reviewed in Kantele et al. 2011). Respiratory distress is correlated with para-
site density. Sequestrations of infected erythrocytes were observed in capillaries of heart, 
kidneys and brains (Cox-Singh et al. 2010).  
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Fig. 10: Blood cycle of P. knowlesi (Source: Coatney 1971) 
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4.8.3 Epidemiology 
In 1965 the first human case of a P. knowlesi was reported in a male American soldier 
working in the rainforests of Peninsular Malaysia (Chin et al. 1965). The patient docu-
mented anorexia, fatigue, nausea, chills, fever and sweating as initial symptoms. The pa-
tient returned to the USA. At the first microscopic blood analysis rings only were ob-
served, whereas at the second analysis band forms were observed and misdiagnosed as P. 
malariae. However, blood was referred to the CDC and was there diagnosed as P. knowlesi 
accidentally. In 1971 a second suspected case was reported from Peninsular Malaysia (re-
viewed in Kantele et al. 2011). 
 
However, it took until 2004 when 120 human P. knowlesi cases were diagnosed with mo-
lecular based tools by the Kuching group around Balbir Singh and Janet Cox-Singh. Since 
those reports many other cases were reported at epidemiological studies in South-East 
Asia, and in tourists (Tab. 3).  
 
Tab. 3: Reported P. knowlesi cases in human (revised after Kantele et al. 2011) 
Country Local Tourists 
Malaysia/Borneo 707 a 4 b 
Brunei/Borneo  1 
Indonesia/Borneo 1 1 
Malaysia/Peninsular 89 1 
Thailand 11 1 c 
Myanmar 33  
Vietnam 5  
Philippines 5 1 
unknown  1 
Overall 857 9 
 
a
 including 137 cases reported by Barber et al. (2011). 
b
 including 1 case documented by Hoosen and Show (2011). 
c
 case reported by Berry et al. (2011) 
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4.9 Diagnosis of malaria 
 
4.9.1 Microscopy 
Clinical diagnosis of malaria is the least expensive form, but it is inaccurate and often leads 
to misdiagnosis due to confusion with other tropical diseases (Wongsrichanalai et al. 
2007). Microscopy still remains the gold standard in malaria diagnosis (WHO 2009b). Ma-
laria diagnosis by microscopy is based on detecting and identifying malaria parasites to 
species level in blood films or thick smears. For thin smears a blood drop of the finger 
prick is spread on a grease-free microscopic slide, air dried and fixed with methanol before 
staining with Giemsa. For thick films a capillary blood drop is spread and air dried. After-
wards the red blood cells are lysed with water to remove the haemoglobin, and stained with 
Giemsa. Thick films are more sensitive with a sensitivity of 4-20 parasites/µl in highly 
expertise laboratories, and 50-100 parasites/µl under field conditions (Payne 1988; 
Dowling and Shute 1966; WHO 1988; Milne et al. 1994). Regarding the specificity thin 
films (diagnosis to species level) are more accurate compared to thick films.  
Malaria microscopy is cost-effective and provides results within a short time period. Fur-
thermore, it allows an accurate diagnosis up to species level, gives information about the 
parasite density, and the result has a direct impact on the patient’s treatment (WHO 
2005b). Microscopes are available in most villages and small laboratories (WHO 2010b). 
However, certain problems are well known; microscopists need accurate training to be able 
to accurately diagnose malaria to species level – even at low parasitemias; unfortunately, 
the training is often insufficient due to limited resources.  
 
4.9.2 Rapid Diagnostic Tests (RDTs) 
Within the last decades several antigen detection techniques for the diagnosis of malaria 
were employed. RDTs in form of card tests, cassettes or dipsticks are simple to use, easily 
transportable, relatively cheap, rapid, specific and more or less sensitive (White 2003). 
Furthermore, RDTs can be stored at high temperatures, which are common in malaria en-
demic countries. More than 25 million RDTs were used for malaria diagnosis in 2005 
(WHO 2006). RDTs are based on the detection of malaria specific antigens in the blood, 
namely histidin rich protein 2 (HRP2), pLDH (parasite lactate dehydrogenase) and aldo-
lase.  
 34 
HRP2 based RDTs are specific for P. falciparum and the most common used RDTs. Its 
sensitivity was described to be similar to microscopy (White and Silamut 1989; Tjitra et al. 
2001). However, HRP2 clears very slowly and RDTs remain positive for up to one month 
after successful falciparum malaria treatment (Mayxay et al. 2001). Furthermore, this test 
remains negative in patients with rare antigen variations of HRP2 (Baker et al. 2005). 
pLDH-RDTs are antigen-capture tests based on monoclonal antibodies to pLDH, and are 
used for the diagnosis of P. falciparum (PfLDH) or as pan-malaria test (WHO 2009). 
pLDH rapidly clears from blood, and the immunochromatographic tests reveal negative 
results within days after successful treatment. Aldolase based RDTs are used for pan-
malaria diagnosis, but are less sensitive than other RDTs (Cho et al. 2011).  
In conclusion, RDTs can not be considered as gold standard in malaria diagnosis, but are 
an essential diagnostic tool in the field outside of health facilities, where no microscope is 
available.   
 
4.9.3 Molecular tools for the diagnosis of Plasmodium sp.  
With the development of the polymerase chain reaction (PCR) technique a new era in the 
diagnosis of Plasmodium sp. was initiated. This method was developed by Kary Mullis in 
1983 and is a scientific technique which allows the amplification of a single or few copies 
of DNA to millions of copies of a partial DNA sequence (Bartlett and Sterling, 2003). A 
PCR consists of cycles of repeated heating and cooling steps (Denaturation, Annealing and 
Extension) to melt DNA and replicate DNA with the use of enzymes (= polymerase). 
Therefore short DNA-fragments (oligonucleotids) - the so called primers - are needed to 
serve as starting points for DNA synthesis (Fig 11). 
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Fig 11: Principles of a PCR reaction (Source: 
http://www.obgynacademy.com/basicsciences/fetology/genetics/) 
 
4.9.3.1 Diagnosis of Plasmodium sp. by nested PCR of the SSU rRNA gene 
4.9.3.1.1 NP-1993 
Genes of the small subunit ribosomal RNA (SSU rRNA) are highly conserved regions, 
which allow not only a discrimination of different Plasmodium species, but can also be 
used for phylogenetic characterization of a wide range of different Plasmodium (Snounou 
and Singh 2002). For the diagnosis of human malaria parasites in 1993 the group around 
Snounou developed a nested PCR technique (NP-1993 protocol) binding in the SSU rRNA 
gene (Snounou et al. 1993). Soon this technique became one of the most used and stan-
dardized PCR techniques for the detection and determination of different human malaria 
parasites. The lower limits of detection were reported to be between a single parasite in 10 
µl blood (0.000002% parasitemia) and 6 parasites/µl (Snounou and Singh 2002, Singh et 
al. 1999). The NP-1993 protocol seemed to be perfectly suitable for epidemiological stud-
ies. In the NP-1993 species-specific rPLU5 and rPLU6 were used for the Nest 1 PCR reac-
tion amplifying a product of about 1,200 bp in size (Snounou 1993). For species determi-
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nation the primers rFAL1 and rFAL2 for P. falciparum (206 bp), rVIV1 and rVIV2 for P. 
vivax (121 bp), rMAL1 and rMAL2 for P. malariae (145 bp) and rOVA1 and rOVA2 for 
P. ovale (787 bp) were used.  
Several modifications of the NP-1993 protocol followed (Singh et al. 1996, Cox-Singh et 
al. 1997). In 1999 the group around Balbir Singh updated the NP-1993 protocol (Singh et 
al. 1999). Instead of the genus-specific Nest 1 primer rPLU6 they used the primer rPLU1. 
The Nest 1 product resulting at the usage of the primers rPLU1 and rPLU5 has a size of 
1,670 bp, and allowed the introduction of a genus-specific Nest 2 PCR with the primers 
rPLU3 and rPLU4 (240 bp). Instead of five PCRs only two PCRs were needed to detect if 
a blood sample is positive for any species of Plasmodium or not. 
 
4.9.3.1.2 NP-2002 – The problem in the diagnosis of P. ovale becomes obvious 
It became obvious that the NP-1993 had some limitations in the diagnosis of P. ovale. 
Some patient samples which were positive for P. ovale in microscopy gave negative results 
within the nested PCR and so the protocol was updated in 2002 (Snounou and Singh 2002). 
The primers for the Nest2 species analysis of P. ovale were changed to a genus-specific 
primer rPLU2 combined with rOVA1. Furthermore, the NP-2002 involved the genus-
specific Nest2 primers rPLU2 and rPLU3 (Fig. 12).   
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Fig. 12: Schematic representation of the primers used in the nested PCR of the SSU rRNA gene according to 
the NP-2002 protocol (Snounou and Singh, 2002; Singh et al. 1999) 
 
4.9.3.1.3 NP-2005 – The problem with P. ovale proceeds 
Until 2005 more than 14 different protocols were published for the diagnosis of P. ovale 
and it became obvious that P. ovale has to be divided into the classic and the variant type. 
In 2005 the group around Calderaro introduced the NP-2005 protocol. Instead of the use of 
the rPLU2 and rOVA1 primers they recommended the use of two primer pairs: rOVA1v 
and rOVA2v for the diagnosis of the variant type of P. ovale and rOVA1 and rOVA2 (NP-
1993 primers) for the determination of the classic form of P. ovale. A comparison of the 
ovale-specific primers NP-1993, NP-2002 and NP-2005 is given in Fig. 13. 
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Fig. 13: Comparison of different NP-protocols for the diagnosis of P. ovale (Source: Calderaro et al. 
2005). 
 
4.9.3.1.4 P. knowlesi – Problems in the diagnosis of this newly recognized malaria 
parasite in human 
Within the last years P. knowlesi, an originally classified simian parasite in South-East 
Asia, was recognized as the fifth human malaria parasite (White 2008). Especially the 
Kuching group around Balbir Singh and Janet Cox-Singh worked with this parasite and its 
molecular detection. For the diagnosis of P. knowlesi primers Pmk8 and Pmk9r were de-
veloped which bind within the region of the NP-2002 Nest 1 product (Singh 2004). How-
ever, this primer pair was found to cross-react with P. vivax genomic DNA within the 
ssrRNA-S gene (Fig. 14). A new set of primers, namely PkF1140 and PkR1550 was de-
signed which can be used for secondary PCR reactions after primary amplification with 
rPLU1 and rPLU5 (Fig. 15) (Imwong et al. 2010).    
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Fig. 14: Visualized amplicons of the primers Pmk8 and Pmk9r, not only binding P. knowlesi (Pk) but also P. 
vivax (Pv) 
 
 
Fig. 15: Primers for diagnosis of P. knowlesi within the ssrRNA genes (Source: Imwong et al. 2010). 
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4.10 Molecular phylogeny of Plasmodium sp. using the mitochondrial 
genome  
 
Phylogenetic studies of the genus Plasmodium are often based on genes of the mitochon-
drial DNA. Mitochondrial genomes of different systematic groups vary in structure, size 
and organization. Those of plants are known to be very large (up to 2,400 kb), whereas the 
mitochondrial genome of Plasmodium falciparum is the smallest one with only 6 kb 
(Knoop and Müller 2009). The mitochondrial genome of malaria parasites is repeated tan-
demly and linear (Wilson and Williamson 1997). It encodes the small- and large subunit 
rRNA (SSU rRNA and LSU rRNA) genes and only 3 protein-coding genes: cytochrome c 
oxidase 1 (cox1) and 3 (cox3), and cytochrome b (cyt b) (reviewed in Hikosaka et al. 
2011).  
 
Many studies have examined the phylogeny of Plasmodium in the last years, and revealed 
new conclusions when compared to the morphologically based systematic before the intro-
duction of molecular techniques. Only a short overview of the newest and most important 
approaches in phylogeny of Plasmodium based on mitochondrial genes is mentioned be-
low.  
Recent studies revealed that most simian parasites (e.g. P. knowlesi) are closely related to 
P. vivax, although their morphology differs (Fig.18; LeClerk 2004). For example, P. simio-
vale looks very similar to P. ovale and was named after their morphological compatibility 
but genetic analysis revealed that P. simiovale is closely related to P. vivax and not P. 
ovale (Fig. 16 and Fig. 19). Furthermore the zoonotic potential of human malaria parasites 
was made visible by way of molecular analysis. Duval et al. (2010) confirmed the presence 
of P. falciparum, P. ovale and P. malariae in African Great Apes (Fig. 16). P. brasilianum, 
a simian parasite of New World monkeys, was found to be genetically identical to P. ma-
lariae (Fig. 17; Tazi et al. 2011, Escalante et al. 1995). It was shown that several malaria 
species can switch hosts, and this had an impact on the relatively quick evolutional diversi-
fication of malaria lineages (Hayakawa et al. 2008). Molecular techniques also allowed the 
introduction of the 5th and “6th” human malaria parasite. In South-East Asia P. knowlesi 
was diagnosed in humans with molecular tools, and based on its molecular dimorphisms P. 
ovale was divided into two new species, namely P. ovale wallikeri and P. ovale curtisi (Fig 
19; Sutherland et al. 2010). 
 41 
 
Fig 16: Phylogeny of malaria parasites based on cyt b and cox1 sequences (Bayesian Values/maximum like-
lihood) (Duval et al. 2010).  
 
 
Fig 17: Phylogenetic relationship among P. malariae and P. brasilianum based on the SSU rRNA gene (Tazi 
et al. 2011). 
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Fig. 18: SSU rRNA based phylogeny of the genus plasmodium with a cladistic consensus tree (Leclerk et al. 
2004).  
 
 
Fig. 19: Unrooted phylogenetic tree based on the mitochondrial cyt b gene (single optimum bifurcating tree) 
(Sutherland et al. 2010).  
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4.11 Malaria treatment, drug resistances and drug susceptibility 
 
Table 4 gives an overview on the drugs used for the treatment of malaria parasites. 
 
Tab. 4: Drugs recommended for malaria treatment (Source: Kasper et al. 2005) 
 
 
 
Multidrug resistances in Plasmodium falciparum compromise malaria treatment and con-
trol. By now resistances to chloroquine are widespread around the tropics. Resistances to 
mefloquine and sulfadoxine/pyrimethamin are observed frequently (Astelbauer and 
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Walochnik 2011, Marma et al. 2010). Recently first reports of resistances to artemisinine 
and artesunate-mefloquine were documented (Noedl et al. 2008; Noedl et al. 2009; Noedl 
et al. 2010; Dondorp et al. 2009; Wongsrichanlai and Meshnick 2008). 
 
Chloroquine can be used for the treatment of blood forms of P. vivax and P. ovale. In areas 
where chloroquine-resistances are known in P. vivax ACTs should be used. Amodiaquine 
and mefloquine are also effective against P. vivax blood forms. For the treatment of hyp-
nozoites of P. vivax and P. ovale primaquine should be given for 14 days to patients with-
out G6PD-deficiency only. Tavenoquine also possesses activity against hypnozoites (re-
viewed in Astelbauer and Walochnik 2011).  
To cure malaria caused by P. malariae chloroquine can be used, although care should be 
taken. First reports of resistances in P. malariae to chloroquine were examined in Indone-
sia (Maguire et al. 2002). 
Until now human P. knowlesi malaria cases were treated with chloroquine, quinine + 
doxycycline, mefloquine, and atvaquone + proguanil (Kantele et al. 2011, Kantele et al. 
2008). A recent study documented full activity of chloroquine against P. knowlesi 
(Daneshvar et al. 2010).  
 
To test the efficacy of drugs in vitro cultivation of Plasmodium sp. is an essential tool 
(WHO 2007). P. falciparum is easy to cultivate – even under field site conditions. Trager 
and Jensen established the cultivation of this pathogen in 1976 and modified protocols of 
this technique are still in use.  
However, until now there are no in vitro cultivation techniques for P. vivax allowing expo-
nential parasite growth for at least 72 hours, which would be necessary to test the efficacy 
of slow acting drugs. Various parasite species possess different preferences to its host cells 
– e.g. P. vivax and P. ovale prefer the invasion of reticulocytes, whereas P. malariae shows 
a tendency to invade older erythrocytes. The problems regarding the cultivation of P. vivax 
are discussed in Chapter 8.5. Several authors reported limited success in the cultivation of 
P. ovale and short time cultivation of P. malariae (Ringwald et al. 1997; Tanariya and Pas-
uralertsakal 1994). Recent studies used modified schizont maturation assays for the culti-
vation of P. malariae and P. ovale (Siswantoro et al. 2011).  
 
 
 45 
4.12 Bangladesh 
 
The people’s republic of Bangladesh is a South Asian country (20° and 27°N and longi-
tudes 88° and 93°E) with an area of 147,569 km2. It is almost entirely surrounded by India 
(West Bengal, Assam, Meghalaya, Tripura and Mizoram), shares a 193 km border with 
Myanmar in the Southeast and the Bay of Bengal (Indian Ocean) in the South. Bangladesh 
has a population of 164.4 million people of whom 60% are below the age of 25 years. The 
population density is 1,100 people/km2 (8th densest in the world). 98% of the population 
are Bengali with Bangla as mother tongue and 90% of the population are Muslims. The 
total fertility rate is high at 2.5 children per woman. Two thirds of the population are farm-
ers and 75% of the Bangladeshi population live outside larger cities. The literacy rate is 
increasing, but is still low at 53.5% in 2007 (UNDP 2009). For both male and female life 
expectancy is 63 years (WHO 2005).  
Bangladesh is a Northern Tropic country with seasonal climate: warm and humid monsoon 
from June to October, mild winter from October to March, and hot, humid summers from 
March to June.   
 
4.12.1 The Chittagong Hill Tracts and the District of Bandarban 
Van Schendel et al. (2001) described the area as following: “South Eastern Bangladesh 
consists of two different distinct geographical parts. On the one hand there is a long narrow 
plain along the Bay of Bengal, on the other hand there is a mountainous region with hills 
up to 1,200 m – the so called Chittagong Hill Tracts (CHTs)”. The CHTs have an area of 
13,180 km2 and can be divided into the districts Bandarban, Rangamati and Khagrachhari.  
The boundary between the plain area in the West and the hilly region in the East is not only 
a geographic one. There is also a cultural division of the South Asian and the South East 
Asian cultural rims. Most of the plain areas in Bangladesh are inhabited by Bengalis, 
whereas the CHTs are home to different non-Bengali ethnical minorities like Marma, 
Chakma, Tripura and Mru (Tab. 5) (van Schendel et al. 2001). There is also a cultural dif-
ferentiation within the various ethnical groups (e.g. food, religion). 
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Tab. 5: Population of the Chittagong Hill Tracts (Source: van Schendel et al. 2001) 
Group Main religion Population (1981) 
Chakma Buddhism 230,000 
Taungchengya Buddhism 20,000 
Marma Buddhism 120,000 
Sak Buddhism 1,500 
Khyeng Community religion 1,500 
Tripura Hinduism 40,000 
Riang/Brong Hinduism 10,000 
Mru Community religion 20,000 
Khumi Community religion 1,000 
Bawn Christianity 8,000 
Pangkhua Christianity 2,000 
Lushai/Mizo Christianity 1,000 
Bengali Islam 290,000 
Total  745,000 
   
The district of Bandarban itself is located in the Southeast of the Chittagong Hill Tracts 
(Chittagong Division). Bandarban District comprises an area of 4,479 km2 and is bounded 
by Arakan (Myanmar) and the river Naf to the south, Arakan and Rangamati district to the 
east, Rangamati District to the north, and Chittagong and Cox's Bazar district to the west. 
Administratively it is divided into 7 upazilas (sub-districts). Those 7 subdistricts are Ban-
darban, Alikadom, Naikhongchari, Ruma, Thanchi, Rowangchari and Lama. The area of 
Bandarban capitol is inhabited by approximately 32,000 people and is 51.80 km2 in size. 
Bandarban is not only the remotest district of the country, but also is the least populated 
one and its natural environment harbours a high variety of plants and animals in its rainfor-
ests. 
The Malaria Research Initiative Bandarban (MARIB) - a field site of the Medical 
University of Vienna (in collaboration with different other organisations e.g. WHO, 
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ICDDR,B) - is based at the Bandarban Sadar Hospital in Bandarban (Fig. 20). The 
Bandarban Sadar Hospital is a district hospital with outpatient and inpatient facilities. 
There are 100 beds in inpatient departments and more than 10 physicians work at the 
hospital. The majority of severe malaria patients within the region are referred to this 
hospital, and about 4,000 falciparum malaria cases are treated there every year. 
 
 
Fig. 20: Location of the MARIB field site in Bandarban District/Bangladesh (map by Markus Fally©) 
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4.13 Malaria Situation in Bangladesh 
 
In Bangladesh 55 million people bear low or high risk of being infected with malaria para-
sites, and 11.4 million thereof reside in high risk areas. In 2009 more than 569,000 sus-
pected malaria cases were documented, of which 79,853 were confirmed. Blood of over 
553,000 patients was analyzed by either microscopy or RDT. Of those 63,873 were diag-
nosed positive for malaria by RDTs (38,670) and microscopy (25,203). Only two species 
were officially reported from Bangladesh in 2009, namely P. falciparum (18,242 con-
firmed cases) and P. vivax (6,853 confirmed cases). In comparison to the years before, 
mortality decreased and caused 47 deaths in 2009 (WHO 2010c).  
 
Eradication programs in the 1970s eliminated malaria in 51 out of 63 districts in Bangla-
desh. In the 1990s malaria re-emerged and became one of the major health problems in 
rural Bangladesh. Malaria is concentrated in 13 hilly and forested districts along the bor-
ders to Myanmar and India, where 98% of all fatal cases had their origin. In the late 1990s 
approximately 900,000 clinical malaria cases were documented, of which only 70,000 
were confirmed by microscopy (WHO 1999). Because of a lack of surveillance and infor-
mation regarding this disease, the malaria situation in Bangladesh was underestimated 
(Bangali et al. 2000; Faiz et al. 2002). In 2005 over 240,000 clinical malaria cases were 
documented; of those 48,121 were clinically confirmed and 501 were of fatal outcome. 
Because of different types of occupation (e.g. hunters, wood cutters) more men than 
women (ratio 54.9% to 45.1%) were affected. P. falciparum is the dominant Plasmodium 
species in Bangladesh causing about 70% of all malaria cases (WHO 2005). In 2005 WHO 
concludes that the malaria situation in Bangladesh and especially in the Chittagong Hill 
Tracts is getting worse. Tab. 6 gives an overview on the malaria situation in the District of 
Bandarban. Resistances to chloroquine and sulfadoxine/pyrimethamine are common in 
those malaria endemic areas, and the Ministry of Public Health introduced an artemisinin-
based combination therapy as first line treatment of uncomplicated falciparum malaria in 
Bangladesh (WHO 2005; Attlmayr et al. 2006; Thriemer et al. 2006). A recent surveillance 
study based on the diagnosis of malaria with RDTs examined a countrywide prevalence of 
P. falciparum of 3.58%, and a prevalence of 0.21% was observed of P. vivax (Haque et al., 
2009).   
Until the start of this thesis project – which was the first PCR corrected cross-sectional 
malaria surveillance in Bangladesh – virtually all malaria cases were diagnosed as P. falci-
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parum or P. vivax (5-8). P. malariae was first documented in Bangladesh in 2004 with a 
prevalence of 1% in the Chittagong Hill Tracts (van der Broek et al. 2004). In 2010 one 
severe P. malariae case was reported from Chittagong (Rahman et al. 2010). However, 
before the start of our studies, neither P. ovale nor P. knowlesi were discussed or docu-
mented to be endemic in Bangladesh. 
 
Table 6: Officially reported malaria cases of microscopically confirmed malaria in Bandarban District from 
2003-2008 (does not include malaria diagnosed by NGOs, private laboratories or self-treatment). 
Year Malaria 
slides exam-
ined 
Microscopically 
confirmed 
malaria 
Plasmodium 
vivax 
Plasmodium 
falciparum 
Severe 
Malaria 
Deaths 
2003 39,075 17,357 2,001 
(11,53%) 
15,356 
(88,47%) 
8,451 108 
2004 37,742 14,460 1,735 
(12,00%) 
12,725 
(88,00%) 
7,424 81 
2005 35,505 12,921 1,318 
(10,20%) 
11,603 
(89,80%) 
7,291 88 
2006 29,943 9,483 1,131 
(11,93%) 
8,352 
(88,07%) 
8,620 71 
2007 30,859 8,507 1,149 
(13,5%) 
7,338 
(86,26%) 
+ 
Mixed infections 
20 
(0,24%) 
8,616 53 
2008 47,216 9,333 1,387 
(14,9%) 
7,691  
(82,4%)  
Mixed infections  
255 
(2,7%) 
2,883 11 
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5 Aims 
 
The primary aims of this study were to determine the distribution, prevalence and phylog-
eny of the less common human malaria parasites P. ovale, P. malariae and P. knowlesi in 
the Chittagong Hill Tracts in Bangladesh, and to establish new techniques for malaria di-
agnosis and P. vivax cultivation. 
 
The first aim was to examine the distribution of P. ovale, P. malariae and P. knowlesi in 
fever patients in Bangladesh. For this purpose a standardized nested PCR binding in con-
served regions of the mitochondrial SSU rRNA genes was employed to classify positive 
malaria samples collected on filter paper to species level.  
 
The second aim was to establish a novel PCR technique using blood spots on filter paper 
which not only allows a faster implementation, but also results in a higher sensitivity com-
pared to standard PCR tools. For this purpose the value of Direct PCR was examined and 
compared to a standard PCR technology. 
 
The third and most important aim was to examine the distribution of a newly discovered 
pathogen in Bangladesh (in 2010 the formerly known species P. ovale was divided by the 
group around Sutherland et al. into P. ovale curtisi -classic form- and P. ovale wallikeri -
variant form) and to analyze the phylogeny of these parasites for the first time in South 
Asia. To determine the presence of these pathogens, more than 2,000 blood samples of 
asymptomatic participants and febrile patients were analyzed with different PCR tech-
niques (different protocols at the SSU rRNA gene, PoTRA gene) and compared to each 
other. P. ovale positive monoinfections were further examined by analysis of partial se-
quences of the SSU rRNA, Cox1 and Porbp2 genes, compared to each other and to previ-
ously published sequences. Furthermore, a closer look at clinical syndromes of infections 
with P. ovale was taken.  
 
The fourth aim of this thesis was to analyse the distribution and phylogeny of P. malariae 
and P. knowlesi in the district of Bandarban by way of PCR and sequence analysis in more 
than 2,000 blood samples collected on filter papers. 
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The fifth goal of this study was to establish a permanent cultivation technique of P. vivax 
under field conditions. More than 90 different cultivation techniques were employed and 
compared to each other.  
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6 Studies 
 
6.1 Status of Peer Reviewed Publications 
 
FUEHRER HP, STARZENGRUBER P, SWOBODA P, KHAN WA, MATT J, LEY B, 
THRIEMER K, HAQUE R, YUNUS EB, HOSSAIN SM, WALOCHNIK J, NOEDL H. 
Indigenous Plasmodium ovale malaria in Bangladesh. Am J Trop Med Hyg. 2010 
Jul;83(1):75-8. 
Impact Factor (2010): 2.446 
 
FUEHRER HP, FALLY MA, HABLER VE, STARZENGRUBER P, SWOBODA P, 
NOEDL H. A novel nested Direct PCR technique for malaria diagnosis from filter 
paper samples. J Clin Microbiol. 2011 Apr;49(4):1628-30. 
Impact Factor (2010): 4.22 
 
FUEHRER HP, HABLER VE, FALLY MA, STARZENGRUBER P, SWOBODA P, 
KHAN WA, BLÖSCHL I, NOEDL H. Variations of Plasmodium ovale in Bangladesh: 
First evidence of the sympatric distribution of P. ovale curtisi and P. ovale wallikeri in 
South Asia. J Infect Dis. – submitted – Dec. 21st 2011 (JID-S-11-02921). 
Impact Factor (2010): 6.228 
 
 
Studies not submitted by now: 
 
Molecular epidemiology of Plasmodium malariae and P. knowlesi in Bangladesh. 
(Chapter 6.5). 
 
A highly sensitive in vitro-assay for the detection and quantification of Plasmodium 
vivax parasite biomass after the usage of different cultivation methods (Chapter 6.6). 
 
Further congress presentations and posters are listed at the end of according chapters and 
within the CV. 
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6.2.1 Abstract  
In spite of the high prevalence of malaria in Southeastern Bangladesh there remains a sig-
nificant shortage of information regarding the presence of three out of five human malaria 
parasites:  Plasmodium ovale, P. malariae, and P. knowlesi. The presence of P. ovale and 
P. knowlesi has never previously been reported from Bangladesh. We used a genus- and 
species-specific nested PCR, targeting highly conserved regions of the small subunit ribo-
somal RNA (SSU rRNA) gene to investigate the presence of malaria parasites in a total 
number of 379 patient samples in a survey of febrile illnesses in the Chittagong Hill Tracts 
in Southeastern Bangladesh. We identified the first cases of P. ovale in Bangladesh. They 
were confirmed by sequence analysis. 189 out of 379 samples (49.9%; 95%CI: 44.9-
54.9%) were positive for Plasmodium sp. by PCR. P. falciparum monoinfections ac-
counted for 68.3% (61.3-74.5%), followed by P. vivax (15.3%; 10.9-21.2%), P. malariae 
(1.6%; 0.5-4.6%), P. ovale (1.6%; 0.5-4.6%), and mixed infections (13.2%; 9.1-18.8%). 
We found no evidence of P. knowlesi in this region.    
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6.2.2 Introduction 
Almost one million people die of malaria every year and recent reports of emerging ar-
temisinin resistance in Southeast Asia will add another challenge to malaria control ef-
forts.1,2,3 High standards in the diagnosis of the malaria-causing Plasmodium species are 
essential to control and adequately treat malaria. In spite of its known limitations micros-
copy remains the gold standard of malaria diagnosis in the field and frequently not even 
microscopy is available in resource-limited environments. This may lead to a significant 
underestimation of the true malaria burden, especially of less prevalent and less docu-
mented species such as P. ovale, P. malariae, and P. knowlesi in Asia.  
The Chittagong Hill Tracts in Southeastern Bangladesh are known to be highly endemic 
for P. falciparum with reported resistance to chloroquine and sulfadoxine/pyrimethamine.4 
Virtually all malaria infections were previously attributed either to P. falciparum or P. 
vivax.5-8 Recent surveillance studies based on the diagnosis with rapid diagnostic tests 
(RDTs) indicate P. falciparum as the dominant species in malaria-endemic districts of 
Bangladesh with a country-wide prevalence of 3.58% (as compared to only 0.21% for P. 
vivax).9 The existence of infections with P. malariae with a prevalence of 1% in Bangla-
desh was first reported from a study conducted in the Chittagong Hill Tracts.11 Both P. 
ovale and P. malariae are typically found at very low prevalences in Southeast Asia.12 P. 
ovale is known to be endemic in sub-Saharan Africa, the Middle East, Irian Jaya and Papua 
New Guinea, but following the availability of PCR-based techniques for the diagnosis of 
malaria this parasite has recently also been reported from a number of countries in South 
and Southeast Asia.13-17 So far infections with P. ovale had not been reported from Bangla-
desh. 
In recent years, human cases of P. knowlesi infections have been reported from Southeast 
Asia, especially by the Kuching group in Malaysia and although originally classified as a 
simian malaria parasite P. knowlesi is now generally recognized as the fifth human malaria 
species.18 PCR-confirmed cases have been documented in Malaysia, Thailand, Myanmar, 
Singapore, and the Philippines.19-25 P. knowlesi has a daily (quotidian) asexual cycle poten-
tially resulting in life-threatening hyperparasitemia and hepatorenal dysfunction. A number 
of fatal cases have been reported from Malaysia.20 Identification of P. knowlesi solely 
based on microscopy remains difficult.19,26 Several Macaque species, including the tradi-
tional hosts of P. knowlesi, have their habitats in Bangladesh, and populations of critically 
endangered Macaca fascicularis are known to be endemic in the very southeastern parts of 
the country.27 The limited distribution of mosquitoes of the Anopheles leucosphyrus group, 
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the only known vector of P. knowlesi,  restrict the current distribution of P. knowlesi to a 
limited area in Southeast and parts of South Asia, including the Chittagong Hill Tracts in 
Bangladesh.29,30  
The primary aim of this study was to establish the prevalence of all 5 malaria species 
among febrile patients in the Chittagong Hill Tracts in Bangladesh with special emphasis 
on the 3 rare malaria species.  
 
6.2.3 Materials and Methods 
Study population. Diagnostic samples were collected from febrile patients in the course of 
field surveys in Bandarban District in the Chittagong Hill Tracts in 2007/2008 and a hospi-
tal-based survey at the MARIB (Malaria Research Initiative Bandarban) field site in 
2008/2009. Male and female volunteers of any age with acute fever or a history of fever 
within the past 72 hours were included in this study. Venous blood was only drawn from 
patients 8 years or older. Written informed consent was obtained from all study partici-
pants or their legal representatives before blood samples were collected. The study proto-
col was reviewed and approved by the Ethical Review Committee of the International Cen-
tre for Diarrhoeal Disease Research, Bangladesh.  
Malaria diagnosis. Thick and thin blood smears were prepared and examined in duplicate 
by two expert microscopists blinded to each other’s results after staining with Giemsa 
(Merck KGaA®, Darmstadt, Germany). In thick films 200 oil-immersion fields were 
screened before declaring a slide negative. If the parasite count on the thick film was too 
numerous to count, the number of parasites per 2000 red blood cells was counted on the 
thin film. RDTs (FalciVax®, Zephyr Biomedicals, India) based on the detection of P. falci-
parum-specific histidine-rich protein 2 (HRP2) and P. vivax-specific lactate dehydrogenase 
(pLDH) were used in 357 patients.  
Blood sample collection for PCR. From all patients over the age of 8 years 100 µL of 
venous whole blood and from children below 8 years 2 drops of finger prick blood were 
transferred onto filter paper (903™ Schleicher & Schuell BioScience GmbH, Dassel, Ger-
many). A total of 379 filter papers were prepared in duplicate, air dried at room tempera-
ture, and stored in airtight containers at 4°C until further processing by PCR. 
DNA Isolation and Purification. A modified chelex-based DNA extraction method using 
the InstaGene™ Whole Blood Kit (Bio-Rad Laboratories, Hercules, CA) was employed 
for the extraction and purification of Plasmodium DNA from the blood spots on filter pa-
per.  
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To ensure comparable quantities of blood, samples of exactly 4 mm in diameter were 
punched out of the blood spots. Blood spots were soaked overnight in 100 µL phosphate-
buffered saline (PBS) at 4°C, and the DNA extraction was performed on the following day 
as previously described.32,33 The resulting supernatant was purified with InstaGene Matrix 
twice.  
Parasite detection by nested PCR. Nested PCR assays were performed as described pre-
viously.34,35 The specific primers bind in highly conserved regions of the small subunit 
ribosomal RNA (SSU rRNA) gene which was used for the detection of genus and/or spe-
cies specific Plasmodium DNA. 
In the nested PCR we used the genus-specific primers rPLU1 and rPLU5 for the first and 
rPLU3 and rPLU4 for the second PCR. Whenever this genus-specific nested PCR gave 
positive results species-specific “Nest 2” PCRs were performed for species determination 
using the following internal primer pairs: rFAL1 and rFAL2 for P. falciparum, rVIV1 and 
rVIV2 for P. vivax, rMAL1 and rMAL2 for P. malariae, rOVA1 and rPLU2 for P. ovale 
(classical type) and Pmk8 and Pmkr9 for P. knowlesi.19,34,35 The oligonucleotides were 
obtained from Microsynth (Microsynth AG, Balgach, Switzerland). 
We used a template of 5 µL DNA in a 50 µL reaction (GoTaq PCR Core System, 
Promega, Madison, USA) for the first amplification and 5 µL Nest 1 product in 50 µL re-
actions for the amplification in Nest 2 (GoTaq PCR Core System). In all experiments a 
negative control of water and known positive controls were run with the samples. The PCR 
products of Nest 2 amplifications were analyzed by gel electrophoresis with 2% agarose 
and ethidium bromide staining. The individual interpreting the PCR results was blinded to 
the results of microscopy and RDT.  
Sequence analysis. The amplicons of the P. ovale-positive samples from the nested PCR 
where further analyzed by sequencing for species confirmation. PCR products were puri-
fied using the Xact DNA Gel extraction Kit (GenXpress, Wiener Neudorf, Austria) and 
sequenced using the BigDye® sequencing kit and an automatic 310 ABI PRISM sequencer 
(PE Applied Biosystems, Germany). 
 
6.2.4 Results 
A total number of 189 out of 379 (49.9%; 95% confidence interval: 44.9-54.9%) filter pa-
pers from patients with febrile illnesses gave positive results for Plasmodium spp. with 
genus-specific primers by nested PCR. All 159 samples classified as positive by micro-
scopic examination were confirmed as being positive. In addition, 30 samples which were 
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diagnosed as negative by microscopy, were positive in the genus-specific nested PCR. 
Species-specific PCR showed that out of 189 Plasmodium spp. positive samples, 154 
(81.5%; 95%CI: 75.3-86.4%) were positive for P. falciparum, 50 (26.5%; 95%CI: 20.7-
33.2%) for P. vivax, 7 (3.7%; 95%CI: 1.8-7.4%) for P. malariae, and 3 for P. ovale (1.6%; 
95%CI: 0.5-4.6%). All samples tested negative for P. knowlesi.  
We found 164 (86.8%; 95%CI: 81.2-91.1%) monoinfections and 25 (13.2%; 95%CI: 9.1-
18.8%) mixed infections. 129 (68.3%; 95%CI: 61.3-74.5%) patients presented with P. fal-
ciparum, 29 (15.3%; 95%CI: 10.9-21.2%) with P. vivax, 3 (1.6%; 95%CI: 0.5-4.6%) with 
P. malariae, and 3 (1.6%; 95%CI: 0.5-4.6%) with P. ovale monoinfections. In addition, 21 
(11.1%; 95%CI: 7.4-16.4%) patient samples contained DNA of both P. falciparum and P. 
vivax, 2 (1.1%; 95%CI: 0.3-3.8%) of P. falciparum and P. malariae and 2 (1.1%; 95%CI: 
0.3-3.8%) triple infections with P. falciparum, P. vivax, and P. malariae (Table 1). One 
patient presented with P. ovale twice in the course of this study. Based on the PCR results 
30 (7.9%; 95%CI: 5.5-10.8%) microscopy slides were classified as false negative and none 
as false positive. In comparison to the 25 PCR-confirmed samples with mixed malaria in-
fections only 9 (36%) were read as positive for mixed infections in microscopy and only 6 
(24%) were diagnosed as mixed infections by RDT. 
All three samples positive for P. ovale in PCR were proven by DNA sequencing and after 
unblinding were also found positive for P. ovale on microscopical re-examination. 
 
6.2.5 Discussion 
For 2006, the World Health Organization estimated almost 3 million malaria cases with 
15,000 deaths in Bangladesh in mostly unconfirmed cases. Among microscopy-confirmed 
malaria infections, P. falciparum was the dominant species causing more than 70% of all 
malaria cases.1 A recent report based on microscopic diagnosis indicated, that 70.3% of all 
malaria cases in the Chittagong Hill Tracts were caused by P. falciparum, 29.6% by P. 
vivax and only 0.01% were read as mixed infections.7 A study using microscopic and mo-
lecular methods for diagnosis conducted between 2000 and 2002 revealed that of those 
slides considered positive for Plasmodium spp., 84% were P. falciparum monoinfections 
or mixed infections, 15% P. vivax and 1% P. malariae.11 Our study shows comparable 
results for P. falciparum with 81.5% (of which 68.3% were monoinfections) and P. vivax 
with 26.5% (of which 15.3% were monoinfections). However, none of the earlier studies 
ever reported any cases of P. ovale. 
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We report the first three cases of P. ovale in Bangladesh. All of them were monoinfections 
and originated from the Chittagong Hill Tracts. Two of the positive samples found in this 
survey were seen in the same patient, who originally tested negative in the RDT but was 
diagnosed with P. malariae based on microscopy (assuming that P. ovale was not an op-
tion as it had never been seen in Bangladesh before). Two months after being treated for 
his suspected P. malariae infection the patient returned with signs and symptoms consis-
tent with malaria. This sample was confirmed to be P. ovale by molecular techniques, sug-
gesting a relapse with P. ovale. 
The nested PCR assay employed in this study is highly sensitive with a documented limit 
of detection of 6 parasites/µL.34 Using the primer pair rOVA1/rPLU2, we selectively 
screened for the so called classic type of P. ovale.36 P. ovale was found in 1.6% of the 
Plasmodium-positive samples. P. ovale had previously been reported from nearby Rakhine 
State in Myanmar. It has also been reported from other parts of Myanmar and a surpris-
ingly high prevalence of up to 6.1% in Tanintharyi Division in 1996.12,37  In the same study 
P. malariae was reported from 15,2% of all cases. Other PCR-based studies in Southeast 
Asia report up to 4% of P. ovale malaria in Northeastern Cambodia and 1.03% in Thai-
land.17,23,36 
The impact of newly emerging pathogens in public health is increasing. Although our data 
do not confirm the presence of P. knowlesi in Bangladesh, our knowledge of the reservoir, 
vectors, and ecology of this malaria parasite indicate that Southeastern Bangladesh may be 
a an environment in which P. knowlesi is likely to be found. Human infections are easily 
mistaken for P. falciparum infections when the parasites are in the stage of young tropho-
zoites.29 In studies based on microscopic diagnosis it may also easily be mistaken for the 
morphologically very similar parasite P. malariae.26 This parasite should therefore always 
be considered whenever patients are from or report a travel history to remote areas of 
Southeast Asia and are diagnosed with P. malariae malaria based on microscopic examina-
tion.28,31  
Relative to microscopy, molecular methods not only tend to improve the sensitivity and 
specificity of diagnostic studies, they also result in higher estimates of malaria prevalence, 
particularly for the rare species P. malariae and P. ovale, and in higher rates of mixed in-
fections.10 Studies conducted in Lao PDR (23.1%), and Northwestern Thailand (23-24%) 
in which molecular techniques were used all suggested the presence of high numbers of 
mixed infections.23,36 In our survey, we found 25 cases (13.2% of all positive samples) of 
mixed infections, of  which the combination of P. falciparum and P. vivax was most fre-
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quently seen. Triple infections with P. falciparum, P. vivax, and P. malariae are rare and 
were found in only two patients coming from the same small village (Nathogri, Row-
anchari Subdistrict).     
Accurate diagnosis of Plasmodium spp. is essential for optimizing malaria treatment guide-
lines. Further studies assessing the prevalence of the rare species P. ovale, P. malariae, and 
P. knowlesi in South Asia are therefore urgently needed to better understand the species 
distribution and to allow for adapting treatment strategies. 
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Table 1: Comparison of malaria diagnosis by nested PCR, Microscopy and FalciVax®-
RDT 
 Neg Pf Pv Pm Po Pk Pf+Pv Pf+Pm Pf+Pv+Pm 
PCRa 190 129 29 3 3 0 21 2 2 
Microscopya 220 122 29 3 0 0 6 0 0 
RDTb 228 108 15 - - - 6 - - 
* neg = negative; Pf = Plasmodium falciparum; Pv = P. vivax; Pm = P. malariae; Po = P. ovale; Pk = P. 
knowlesi; Pf+Pv = P. falciparum + P. vivax; Pf +Pm = P. falciparum + P. malariae; Pf+Pv+Pm = P. fal-
ciparum + P. vivax + P. malariae 
a
 nPCR = nmicroscopy = 379 
b
 nRDT = 357; Diagnosis of Pm, Po, Pk are not possible with FalciVax®-RDTs 
 67 
 
6.3 A novel nested Direct PCR technique for malaria diagnosis  
from filter paper samples 
 
Hans-Peter FUEHRER1,2, Markus A. FALLY1,2, Verena E. HABLER1,2, Peter 
STARZENGRUBER1,2, Paul SWOBODA1,2 & Harald NOEDL1,2* 
 
 
1
 Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vi-
enna, Vienna, Austria  
2
 MARIB, Malaria Research Initiative Bandarban, Bandarban, Bangladesh 
 
 
 
 
Running title: Detection of Plasmodium spp. with Direct nested PCR 
 
Correspondence footnote: Harald Noedl  
Department of Specific Prophylaxis and Tropical Medicine  
Medical University of Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria  
Telephone: #43-1-40490-64882, FAX: #43-1-40490-64899 
E-mail: harald.noedl@meduniwien.ac.at  
 68 
6.3.1 Abstract  
The use of Direct nested PCR enables the detection of Plasmodium spp. from blood sam-
ples collected on filter papers without requiring the time-consuming procedures associated 
with DNA extraction. Direct PCR provides a rapid, highly sensitive, and cost effective 
alternative to diagnosing malaria on filter paper samples by standard nested PCR. 
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6.3.2 Introduction 
Malaria remains a major global health burden with an estimated death toll of almost 
900,000 every year.11 Recent reports of newly emerging artemisinin resistance and the 
emergence of endemic populations of a number of “new”, potentially human pathongenic 
Plasmodium species such as P. knowlesi as well as a variety of P. ovale parasites in Asia 
mean that there is an urgent need for new techniques to provide rapid and highly accurate 
diagnosis to adequately treat and control malaria.3, 5, 9  
The use of Direct PCR allows for PCR amplifications without any prior DNA extraction 
and purification steps. The Phusion® blood DNA polymerase used in the assay is reported 
to lead to a 25-fold lower error rate in comparison with common Thermus aquaticus poly-
merase.2  
The aim of this study was to adapt this novel technique for use in the rapid lab-based diag-
nosis of Plasmodium spp. and validate the sensitivity in comparison to conventional nested 
PCR and microscopy.6,8  
 
6.3.3 Methods 
Patient samples were collected between 2007 and 2009 at the MARIB (Malaria Research 
Initiative Bandarban) center in Bandarban, Chittagong Hill Tracts, Bangladesh, as part of a 
hospital and field-based fever survey. Written informed consent was obtained from all 
study participants or their legal representatives and the study protocol was approved by the 
respective ethical review committee.  
From all participating patients aged 8 years and above, 100 µl venous blood was drawn. 
From patients below this age, 2 drops of finger-prick blood were collected and transferred 
onto filter paper (903™ Schleicher & Schuell BioScience GmBH, Dassel, Germany) in 
duplicate. Filter papers were air dried at room temperature and stored airtight at 4°C until 
further processing. A total number of 140 filter paper samples was included in the evalua-
tion.   
 
Direct nested PCR. A blood spot 2 mm in diameter was punched out of each filter paper 
sample and washed with 30 µl double distilled water at 50°C for 3 minutes. The water was 
removed and the PCR mix (Phusion® Blood Direct PCR Kit, Finnzymes OY, Espo, 
Finnland) was added directly to the sample. A modified standard nested PCR protocol was 
used for the evaluation of genus- and species-specific Plasmodium DNA within the highly 
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conserved regions of the small subunit ribosomal RNA (SSU rRNA) gene.6, 7, 8 Following 
primers were used: rPLU1/rPLU5 for the Nest 1 reactions and rPLU3/rPLU4 for the ge-
nus-specific Nest 2 amplifications. Whenever the genus-specific Nest 2 PCR revealed posi-
tive results, species-specific Nest 2 primers were used to determine the species: 
rFAL1/rFAL2 (P. falciparum), rVIV1/rVIV2 (P. vivax), rMAL1/rMAL2 (P. malariae), 
rOVA1/rPLU2 (P. ovale) and Pmk8/Pmkr9 (P. knowlesi). All oligonucleotide primers 
were obtained from Microsynth (Microsynth AG, Balgach, Switzerland).  
 A 50 µl Nest 1 reaction was set including 25 µl 2x Phusion® Blood PCR Buffer (which 
included 200 µM dNTPs and 3mM MgCl2), 1 µl (2 U) Phusion® Blood DNA Polymerase, 
and 5 µl of each primer (rPLU1 and rPLU5 – 10 µM) according to the manufacturer’s 
manual2. The DNA was denatured at 98°C for 4 min, followed by 25 cycles of amplifica-
tion (annealing: 65°C for 2 min, extension: 72°C for 2 min, denaturation: 94°C for 1 min). 
After 25 cycles the final extension was set at 72°C for 4 min using an Eppendorf Master-
cycler Personal (Eppendorf AG, Hamburg, Germany). The annealing temperature was de-
termined using the Tm calculator on the manufacturer’s website 
(https://www.finnzymes.fi/tm_determination.html).2 The resulting Nest 1 PCR product was 
centrifuged at 1,000 x g for 3 minutes. 2.5 µl Nest 1 products (same in standard nested 
PCR and direct nested PCR) were used in 25 µl Nest 2 amplifications (GoTaq PCR Core 
System, Promega, Madison, USA). 
 Known positive control samples and nuclease free water as negative control were run with 
each PCR amplification. Nest 2 PCR products were analyzed by gel-electrophoresis with 
2% agarose and ethidium bromide staining.  
 
Standard nested PCR-technique. A modified chelex-based method using an InstaGene™ 
Whole Blood Kit (Bio-Rad Laboratories, Hercules, CA) was used to extract DNA from 
blood spots on filter paper. A blood spot of 4 mm in diameter was punched out and soaked 
overnight in 100 µl phosphate-buffered saline (PBS) at 4°C. DNA extraction was per-
formed on the following day as described previously.1 All samples were purified twice 
with the InstaGene matrix and stored at -20°C until further processing.  
A template of 5 µl was used in a 50 µl Nest 1 reaction (GoTaq PCR Core System, 
Promega, Madison, USA) under the following conditions: 5 µl of each primer (10 µM), 
125 µM of each dNTP, 2 mM of MgCl2 and 1 U of GoTaq® DNA-polymerase.   
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Nest 2 reactions and further procedures (with the exception of the centrifugation step of the 
Direct PCR Nest 1 product) were identical to the standard - and Direct nested PCR tech-
niques discussed above.  
 
Microscopy. Thick and thin smears were prepared in duplicate from each patient’s blood 
and stained with Giemsa (Merck KGaA®, Darmstadt, Germany). Each slide was examined 
by two expert microscopists blinded to each other’s results. In thick films, 200 oil-
immersion fields were evaluated before a sample was declared negative and to rule out 
mixed infections. On thin films the parasite count was established per 2000 red blood cells.  
 
6.3.4 Results and Discussion.  
The level of detection was determined in double-blinded fashion (each step blinded to the 
results of each other: microscopy, DNA extraction, PCRs, and gel electrophoresis) using 
filter papers with 100 µl blood spots with known parasitemia obtained from the K1 (1 
parasite/µl – 250,000 parasites/µl) and 3D7 Plasmodium falciparum strains (1 parasite/µl – 
290,000 parasites/µl), as well as a Plasmodium vivax isolate (1 parasite/µl – 30,000 para-
sites/µl),. The lowest parasitemia reliably resulting in positive results was 3 parasites/µl for 
the Plasmodium vivax isolate and the K1 strain isolate, and 5 parasites/µl for the 3D7 labo-
ratory strain. 
Using Direct nested PCR 95 of 140 field isolates gave positive results with genus-specific 
primers as compared to 92 of 140 using standard nested PCR and 89 of 140 using micro-
scopic determination (Table 2). Based on a total of 640 Nest 2 PCRs (genus and species) a 
sensitivity of 99.8%, a specificity of 96%, a positive predictive value (PPV) of 90.9% and 
a negative predictive value (NPV) of 99.7% in comparison to standard nested PCR were 
calculated (Table 1). All field isolates giving positive results for malaria parasites in mi-
croscopy remained positive in Direct nested PCR. The limitations in terms of specificity of 
the primers in the detection of P. ovale and P. knowlesi has previously been discussed.4, 9  
Although microscopy remains the gold standard for malaria diagnosis the limit of detection 
may significantly differ between microscopists and has previously been estimated at a 
parasitemia of 50-100 parasites/µl under field conditions.10 Despite their known limita-
tions, microscopy and/or Rapid Diagnostic Tests (RDTs) remain the primary techniques of 
malaria diagnosis. However, in the past decades the improvement of molecular diagnostic 
tools (e.g. PCR, real-time PCR) has resulted in the availability of far more sensitive tools.  
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With only 3 parasites/µl the novel assay is likely to be slightly more sensitive than standard 
nested PCR with its limit of detection of 6 parasites/µl.6 The calculated value for the speci-
ficity (96%) and the PPV (90.9%) relative to standard PCR (PCR corrected microscopy) 
may possibly under-/overestimate the true specificity as the higher proportion of positive 
samples found by Direct PCR could possibly also be a result of the higher sensitivity of the 
new assay.  
Certainly the biggest advantage of Direct PCR is the fact that the extraction and purifica-
tion of DNA from filter paper can be omitted, resulting in an overall saving in time of ap-
proximately 2 hours, plus the overnight DNA extraction step, which in our eyes justifies 
the slightly higher price of each single direct Nest 1 PCR reaction (~ 2.1 US$) in compari-
son to the standard Nest 1 PCR (1.7 US$) for the DNA extraction and Nest 1 reaction of 
one sample. At the same time the collection of filter papers is a practical way of sampling, 
storing, and transporting diagnostic blood samples. This technique is not limited to screen-
ing for malaria parasite species, it might equally be employed for genotyping, drug resis-
tance research, as well as for the diagnosis of other blood pathogens. We therefore con-
clude that Direct PCR in combination with the collection of blood samples on filter paper 
provides a rapid, highly sensitive, and cost effective alternative for malaria diagnosis.   
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Table 1: Comparison of Plasmodium sp. diagnosis by standard nested PCR and by Direct 
nested PCR. 
 Standard nested PCR  
Direct PCR  Neg Pf Pv Pm Po Pk Pf+Pv Pf+Pm Pf+Pv+Pm 
 
Total 
Neg 45a         45 
Pf  59     1   60 
Pv 1  6       7 
Pm 1   2      3 
Po 1    4     5 
Pk      0    0 
Pf+Pv  4     7   11 
Pf+Pm  1  2    2  5 
Pv+Pm   2       2 
Pf+Pv+Pm         1 1 
Pf+Pv+Pm+Po         1 1 
Total 48 64 8 4 4 0 8 2 2 140 
* neg = negative; Pf = Plasmodium falciparum; Pv = P. vivax; Pm = P. malariae; Po = P. ovale; Pk = P. 
knowlesi; Pf+Pv = P. falciparum + P. vivax; Pf +Pm = P. falciparum + P. malariae; Pf+Pv+Pm = P. fal-
ciparum + P. vivax + P. malariae; Pf+Pv+Pm+Po = P. falciparum + P. vivax + P. malariae + P. ovale. 
a
 including 2 samples negative in standard nested PCR, which gave positive results in genus-Direct 
nested PCR but remained negative in the species direct nested PCRs and after repeating the genus-Direct 
nested PCRs. 
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Table 2: Comparison of malaria diagnosis by Direct nested PCR, nested PCR and 
Microscopy with the inclusion of all samples (n = 140) and only those negative in 
microscopy or with a parasitemia of 200/µl or below (n = 61). 
 Overall Parasitemia ≤ 200/µl 
or not detected with 
microscopy 
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neg 45 48 51 45 48 51 
Pf 60 65 72 5 4 9 
Pv 7 8 9 1 1 1 
Pm 3 3 2 1 1 0 
Po 5 4 3 2 1 0 
Pf + Pv 11 8 3 4 4 0 
Pf + Pm 5 2 0 2 1 0 
Pf + Pv + Pm 1 2 0 0 1 0 
Pf + Pv + Pm + Po 1 0 0 1 0 0 
Pv + Pm 2 0 0 0 0 0 
Pk 0 0 0 0 0 0 
 
* neg = negative; Pf = Plasmodium falciparum; Pv = P. vivax; Pm = P. malariae; Po = P. ovale; Pk = P. 
knowlesi 
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6.4.1 Abstract 
Background. In spite of the high prevalence of malaria in Bangladesh and other South 
Asian countries, there remains a substantial shortage of knowledge about the less common 
human malaria parasites. Recent studies indicate that P. ovale itself, is made up of two 
species, namely Plasmodium ovale wallikeri and Plasmodium ovale curtisi.  
Methods. Genus- and species-specific nested PCR analysis of the small subunit ribosomal 
RNA (SSU rRNA) gene was used to detect Plasmodium ovale infections in 2,246 diagnos-
tic samples. Plasmodium ovale infections were further differentiated by nested PCR of the 
potra gene and multilocus analysis of the cox1, porbp2 and the SSU rRNA genes.       
Results. Both P. ovale curtisi and P. ovale wallikeri occur sympatrically in the Chittagong 
Hill Tracts and are associated with a mild or asymptomatic symptom complex. The patho-
gens can be differentiated by nested PCRs targeting the SSU rRNA and potra genes, and 
display dimorphism in multilocus analysis.  
Conclusions. We report the first evidence of sympatric P. ovale curtisi and P. ovale wal-
likeri in South Asia and within a relatively confined study area of less than 5,000 km2. 
High rates of mixed infections, the emergence of “new” human malaria species and the 
evidence of zoonotic capability call for optimized diagnostic strategies for a new eradica-
tion era. 
 
 
 
 
Keywords  
Plasmodium ovale curtisi, Plasmodium ovale wallikeri, Bangladesh, cox1, porbp2, SSU 
rRNA, potra 
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6.4.2 Background 
Since the introduction of molecular tools the number of parasite species known to cause 
human malaria increased from formerly 4 to 6 species within just a few years; namely: 
Plasmodium falciparum, P. vivax, P. malariae, P. knowlesi, P. ovale curtisi (classic type) 
and P. ovale wallikeri (variant type) [1, 2]. Because most scientific efforts are focused on 
P. falciparum and P. vivax only, there is a lack of knowledge regarding the less common 
Plasmodium species, including the recently divided species P. ovale [1]. 
 
Because of their tertian periodicity and their morphological resemblance P. ovale and P. 
vivax are frequently confused [3]. Until fairly recently the distribution pattern of P. ovale 
was considered to be limited to tropical regions in sub-Saharan Africa, Papua New Guinea, 
parts of Indonesia (e.g. Timor, Flores, West-Papua) and the Philippines [4].With the intro-
duction of polymerase chain reaction (PCR)-based techniques, which allow a faster and 
more accurate differentiation of Plasmodium species than microscopy, P. ovale was found 
to have a far wider distribution than previously anticipated. In the meantime P. ovale has 
been documented in nearly all countries of South and South-East Asia, including the South 
Asian countries Bangladesh, India and Sri Lanka [5, 6, 7]. However, information about this 
parasite from Asia remains limited [4]. 
Difficulties in the diagnosis of P. ovale are not limited to microscopy. Even molecular 
analysis has previously resulted in inconsistent results. In 1993 Snounou et al. introduced a 
species-specific nested PCR technique targeting conserved regions of the small subunit 
ribosomal RNA (SSU rRNA) gene which quickly emerged as a standard methodology in 
the molecular identification of Plasmodium species [8]. “Species”-specific primers rOVA1 
and rOVA2 (NP 1993) were used for the diagnosis of ovale malaria. However, selected 
samples positive for P. ovale by microscopy consistently gave negative results by PCR. 
Because of known sequence variations the set of primers was adapted in 2002 (NP2002) 
[9]. In spite of the use of a genus-specific primer, namely rPLU2, in combination with 
rOVA1 a number of microscopically confirmed samples remained negative prompting the 
differentiation of the classic form of P. ovale (binding at the NP1993 primers) and the 
variant type. In 2005 specific primers rOVA1v and rOVA2v were designed to diagnose 
variant forms of P. ovale [10]. Several studies suggested that the genetic polymorphisms 
are not limited to the SSU rRNA. Documented differences between the classic and variant 
types of P. ovale include the cytb gene (encoding the cytochrome b protein), genes encod-
ing lactate dehydrogenase (LDH) and ookinete surface antigens, Cox1 (cytochrome c oxi-
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dase 1 gene), Porbp2 (Plasmodium ovale reticulocyte binding protein 2 gene), PoTRA 
(Plasmodium ovale tryptophan rich antigen gene), pog3p (encoding the glyceraldehyde-3-
phosphatase) and podhfr-ts (encoding the dihydrofolate reductase-thymidylate synthase) 
[1, 11, 12, 13, 14]. 
Thus genetic polymorphisms of P. ovale led to the introduction and segregation of P. ovale 
into two species, namely P. ovale curtisi (former classic type) and P. ovale wallikeri (for-
mer variant type) in 2010 [1]. 
 
After the first description of P. ovale in Bangladesh and the first report of a relapse caused 
by this pathogen in the Chittagong Hill Tracts we hypothesized that P. ovale curtisi and P. 
ovale wallikeri may both be endemic and occur sympatrically in the Chittagong Hill Tracts 
in Bangladesh [5, 15]. To address this hypothesis over 2,200 blood samples from Bangla-
desh were analyzed using a variety of PCR techniques (e.g. SSU rRNA gene) for the differ-
entiation of P. ovale curtisi and P. ovale wallikeri. Multilocus genetic analyses were per-
formed to explore genetic variations of P. ovale and correlated with clinical, parasite and 
demographic data to provide evidence of both species in South Asia and their sympatric 
distribution within a confined area.    
 
6.4.3 Methods 
Study area and population. The district of Bandarban comprises an area of of 4,479 km2 
and is located in the very southeast of Bangladesh bordering Myanmar. Bandarban is part 
of the Chittagong Hill Tracts which are known to be endemic for malaria with the highest 
malaria prevalence in Bangladesh. The district itself is divided in 7 subdistricts, namely 
Bandarban, Alikadom, Naikhongchari, Ruma, Thanchi, Rowangchari and Lama (Fig. 1). In 
the course of field surveys and a hospital-based fever survey at the MARIB (Malaria Re-
search Initiative Bandarban) field site blood samples from 1,867 asymptomatic and 379 
febrile patients were collected in the Bandarban District in 2007 and 2008. Patients pre-
senting with fever or reporting fever within the last 72 hours were included in the fever 
survey, whereas asymptomatic participants took part in the asymptomatic prevalence 
study. Written informed consent was obtained from each participant or their legal represen-
tatives before blood collection. The study protocol was reviewed and approved by the re-
spective ethical review committee. 
Malaria diagnosis by microscopy and sample collection. For malaria diagnosis thin and 
thick blood films were prepared and stained with Giemsa (Merck KGaA, Darmstadt, Ger-
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many). The slides were examined in duplicate by two expert microscopists blinded to each 
other’s result. At least 200 oil immersion fields were screened in thick smears before defin-
ing a slide negative. From each participant 8 years or older 100 µl venous blood were col-
lected, whereas two drops of finger prick blood were taken from children < 8 years, and 
transferred on filter paper (903; Schleicher&Schuell, BioScience GmbH, Dassel, Ger-
many). Filter paper samples were air dried at room temperature, sealed airtight and stored 
until further processing.        
DNA-isolation and preliminary PCR analysis. DNA was extracted from blood spots on 
filter paper using a modified chelex-based technique [5, 16, 17]. To obtain a subset of P. 
ovale positive DNA samples a total of 2,246 DNA samples were examined for Plasmo-
dium infections using nested PCR assays of the small subunit ribosomal RNA (SSU rRNA) 
gene as described previously [8, 9, 18]. Plasmodium genus-specific primers rPLU1 and 
rPLU5 were used for the Nest 1 PCR amplifications and rPLU3 and rPLU4 for Nest 2 
PCRs under conditions described previously [5]. If genus-specific Nest 2 reactions re-
vealed positive results following species-specific primers were used for Nest 2 PCR ampli-
fications: rFAL1 + rFAL2 (P. falciparum), rVIV1 + rVIV2 (P. vivax), rMAL1 + rMAL2 
(P. malariae), rOVA1 and rOVA2 (P. ovale – NP1993 primers), rOVA1 + rPLU2 (P. 
ovale – NP2002 primers), rOVA1var + rOVA2var (P. ovale variation primers) and Pmk8 + 
Pmkr9 (P. knowlesi) [8, 9, 10, 19]. All conventional PCR amplifications were performed 
using an Eppendorf Mastercycler Personal (Eppendorf AG, Hamburg, Germany) and ana-
lyzed by gel electrophoresis. 
PoTRA-PCRs (Plasmodium ovale tryptophan rich antigen gene). Samples testing posi-
tive for P. ovale within the preliminary PCR amplifications were analyzed with PoTRA-
Nested PCRs for the discrimination and confirmation of P. ovale wallikeri (PoW) and P. 
ovale curtisi (PoC) using the primers PoTRA fwd3 + PoTRA rev3 and PoTRA fwd5 + 
PoTRA rev5  as described previously [1, 20]. 
Genetic diversity of P. ovale. Confirmed P. ovale monoinfections were also characterized 
using following genes: Cox1 (cytochrome c oxidase 1 gene), Porbp2 (Plasmodium ovale 
reticulocyte binding protein 2 gene), and SSU rRNA gene.  
Cox1. Haemasporidia-specific Nest 1 primers cox1a + cox1b and Nest 2 primers cox1c + 
cox1d were used to amplify a 964-bp fragment with conditions described previously [14]. 
Cox1c + cox1d were used for sequencing.  
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PoRBP2. PoRBP2fwd + PoRBP2rev were used to obtain Nest 1 amplifications within the 
Plasmodium ovale reticulocyte binding protein 2 gene. For sequencing the internal primers 
PoRBP2TMfwd and PoRBP2TMrev were used [20]. 
SSU rRNA. Two sets of primers, rPLU1 + rPLU5, were used for the Nest 1 reaction as in 
the standard nested PCR described above. Because of the limited amount of DNA resulting 
from the Nest 1 reaction, we chose the internal genus-specific primers rPLU2 + rPLU3 
which were also used for sequencing. 
Sequence analysis. All amplicons of the P. ovale-positive PCR products from monoinfec-
tions were purified with ExoSap-IT® (GE Healthcare, Buckinghamshire, UK) to remove 
incorporated nucleotides and primers, and sequenced using the BigDye Sequencing Kit and 
an automatic 310 ABI PRISM sequencer (PE Applied Biosystems, Weiterstadt, Germany). 
From each patient sample and gene locus three amplicons were sequenced with forward 
and reverse primers discussed above. Sequences were aligned using ClustalX v. 2.0.12 
software [21]. The alignment had 737 positions of which 18 were excluded from the analy-
ses as they showed variations in the sequence length. Calculations of models for sequence 
evolution were performed with jModeltest v. 0.1.1. [22] resulting in the selection of the 
model HKY [31] and a gamma distribution, allowing rate variation between sites. Bayesian 
analyses were performed using MrBayes v. 3.1.2 [23]. The runs were started with random 
trees and performed for 5 million generations each with four Markov chains and a sam-
pling frequency of one of hundred per generation. Data sampled from the generations pre-
ceding the stationary of the Markov chain (25%) were discarded before calculating the 
consensus tree. A Neighbor-joining [32] dendrogram was calculated with ClustalX v. 
2.0.12 using p-distances (1000 bootstrap replicates) [21]. Tree analyses was performed 
with the cox1 sequences of the newly retrieved samples and P. gonderi as an outgroup. 
 
6.4.4 Results  
P. ovale in Bangladesh 
Out of 2,246 diagnostic samples 740 tested positive for Plasmodium spp. by PCR-
corrected microscopy. A total number of 23 out of 2,246 (1.02%; 95% confidence interval 
(CI) = 0.7-1.5%) filter papers gave positive results for P. ovale within the preliminary PCR 
examination of the SSU rRNA gene (Tab. 1). Among these 10 (0.45%; CI = 0.3-0.8) were 
classified as P. ovale curtisi, 12 (0.53%; CI = 0.3-0.9%) as P. ovale wallikeri and one pa-
tient presented both P. ovale curtisi and P. ovale wallikeri (0.04%; CI = 0-0.2%). Mono-
infections with P. ovale curtisi were diagnosed in 4 (36.4%) blood samples, whereas mixed 
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infections were present in 7 (63.6%) (Tab. 2). P. ovale wallikeri mono-infections were 
diagnosed in 6 (46.1%) participants, and mixed infections were documented in 7 (53.9%). 
These results confirm the sympatric distribution of P. ovale curtisi and P. ovale wallikeri 
in a single district with both P. ovale species being documented in 4 of 7 subdistricts (Fig. 
1). 
The gender ratio between female and male ovale malaria-infected persons was 11 (47.8%) 
to 12 (52.2%). Twenty two of 23 (95.7%) participants reported to have been infected with 
Plasmodium spp. in the past.   
P. ovale in symptomatic patients 
Four of 379 (1.05%; CI = 0.4-2.7%) blood samples collected from symptomatic patients 
presenting with febrile illnesses (fever within the last 72 hours) were positive for P. ovale, 
out of which 1 (0.26%; CI = 0.1-1.5%) was determined to be P. ovale curtisi and 3 (0.79%; 
CI = 0.3-2.3%) gave positive results for P. ovale wallikeri.  
The 4 symptomatic ovale malaria patients had parasite densities between 280 and 6,680 
parasites/µl and tested positive for malaria by microscopy. However, none were diagnosed 
as P. ovale, as during enrolment P. ovale was not known to be endemic in Bangladesh 
(Tab. 1).  
P. ovale in asymptomatic participants 
Among asymptomatic participants 19 of 1,867 (1.02%, CI = 0.7-1.6%) filter papers tested 
positive for P. ovale, out of which 9 (0.48%; CI = 0.3-0.9%) each were classified as P. 
ovale curtisi and P. ovale wallikeri, respectively, and one patient (0.05%, CI = 0-0.5%) 
presenting with both. Overall 551 participants tested positive for malaria by PCR-corrected 
microscopy with P. ovale contributing 19 (3.44%; CI = 2.2-5.3%) cases.  
Comparison of diagnostic methods 
Within the SSU rRNA gene three standardized pairs of primers were tested. The classic 
NP-1993 primers rOVA1-rOVA2 resulted in positive results for 11 specimens (Tab. 2) and 
were found to be specific for P. ovale curtisi. rOVA1-rOVA2 gave positive results in 18 
isolates. The variant primers rOVA1v-rOVA2v gave positive results in 13 specimens of P. 
ovale wallikeri. The PoTRA PCR was established after the differentiation of the two P. 
ovale species amplified fragments with sizes of 317 bp for P. ovale curtisi and 245 bp for 
P. ovale wallikeri, and allowed for a discrimination of the two species.  
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Genetic diversity of P. ovale 
 To confirm the presence and genetic diversity of P. ovale in Bangladesh we investigated 
two mitochondrial genes (cox1 and SSU rRNA) and one nuclear gene (Porbp2) in blood 
samples with monoinfections (Tab. 3). Sequence analysis of these genes allowed for a reli-
able discrimination of P. ovale curtisi and P. ovale wallikeri.  
Partial Cox1 gene sequences of 10 isolates confirmed the PCR results within the SSU rRNA 
gene. Six samples of P. ovale wallikeri were identical to human and chimpanzee variant 
parasite strains and 4 P. ovale curtisi were identical to those of classic P. ovale isolates 
(Tab. 3). Dimorphism between the two species was found in 12 loci, but no variability of 
the sequences within each P. ovale species was observed.  
On the basis of partial sequences of the ssrRNA gene the classic or variant status of 8 iso-
lates was determined. Six P. ovale wallikeri and 3 P. ovale curtisi possessed dimorphic 
characters (Tab. 4). All 3 P. ovale curtisi samples were identical to an isolate from Guinea-
Bissau (GQ183068). Furthermore P. ovale wallikeri isolates showed intraspecific variabil-
ity and were comparable to isolates from Thailand, Sao Tome and Cameroon (Fig. 2).  
Eight samples (5 P. ovale wallikeri and 3 P. ovale curtisi) were compared based on partial 
sequences of the Porbp2 gene and dimorphism was observed in 21 loci (Tab. 4). Two P. 
ovale wallikeri samples Po2 and Po3 (JF894423 and JF894424), which were identical in 
the partial sequences of the Cox1 and SSU rRNA genes, varied with one substitution from 
those of other P. ovale wallikeri sequences.  
 
6.4.5 Discussion 
Although for almost a century P. ovale has essentially been known as the African malaria 
parasite, more recently Asian prevalence rates similar to those in Africa seem to suggest a 
much more global distribution.  
The Chittagong Hill Tracts in Bangladesh are known to be highly endemic for P. falcipa-
rum with known resistance to sulfadoxine/pyrimethamine and chloroquine [24]. Until very 
recently the diagnosis of malaria in this rural area was limited to P. falciparum and P. 
vivax, largely because based on microscopic and rapid diagnostic tests neither P. ovale nor 
P. malariae were known to be endemic in this region [5, 25]. With 81.5% (of which 68.3% 
were monoinfections) a recent molecular study implicated P. falciparum as the dominant 
species in the Chittagong Hill Tracts, followed by P. vivax with 26.5% (of which 15.3% 
were monoinfections), P. malariae with 3.7% and P. ovale (variant type) with 1.6% [5]. 
Using the primer pairs selected for the differentiation of the variant and classic P. ovale 
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types we found P. ovale in 3.44% of all malaria-positive asymptomatic participants (P. 
ovale wallikeri and P. ovale curtisi: 1.63% each, and one patient infected with both patho-
gens) and in 2.12% of all symptomatic malaria-positive patients (1.59% P. ovale wallikeri 
and 0.53% P. ovale curtisi) [10]. Previous studies conducted in Rhakine State in Myanmar 
described P. ovale prevalence rates of up to 6.1% [26, 27].  
For Southeast Asia prevalences of 1.03% in Thailand and up to 4% in northeastern Cam-
bodia have been reported [28, 29]. So far none of the prevalence studies conducted in Asia 
addressed the differentiation of the newly introduced P. ovale wallikeri and P. ovale cur-
tisi, although phylogenetic studies refer to the existence of classic and variant forms in 
Myanmar and Thailand [11, 26, 29]. In Asia P. ovale wallikeri has so far only been de-
scribed in samples from Thailand, Vietnam and Papua New Guinea in the course of a sin-
gle study [1]. A study conducted in Congo, Equatorial-Guinea and Uganda confirmed the 
sympatric distribution of both species in Sub-Saharan Africa with an overall prevalence of 
3.1% of all malaria cases [20]. Within our study we were able to prove the sympatric dis-
tribution of P. ovale curtisi and P. ovale wallikeri in South Asia in a relatively confined 
area of less than 5,000 km2.   
 
Both P. ovale species seemed to evoke similar, mostly mild symptom complexes and more 
than half of the P. ovale infections were asymptomatic, which may have major implica-
tions for P. ovale control efforts. The parasitaemias seen in monoinfections were between 
120 and 6,680 parasites/µl, and are therefore considerably below the maximum parasite 
densities achievable in experimentally induced infections [3].  
 
The emergence of “new” malaria parasites (e.g. P. ovale curtisi, P. ovale wallikeri, P. 
knowlesi) and new evidence of zoonotic activity of human malaria parasites may further 
complicate plans to eradicate malaria. Chimpanzees have been used as experimental mod-
els for P. ovale curtisi [1]. Interestingly the cox1 sequence of a variant type P. ovale sam-
ple collected from a free-living chimpanzee in Cameroon (FJ409569) was identical to all 
P. ovale wallikeri samples analyzed in our study [14]. 
 
P. ovale curtisi and P. ovale wallikeri as distinct nonrecombining species showed an esti-
mated divergence between 1-3 MYA [1]. We observed phylogenetic species differences 
among cox1, SSU rRNA, and Porbp2 sequences, as documented previously [1, 14]. Our 
data suggest that PoTRA nested PCR and the combination of the classic primers rOVA1-
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rOVA2 and the variant primers rOVA1v-rOVA2v may be suited best for species discrimi-
nation.  
 
We report the first evidence of sympatric P. ovale curtisi and P. ovale wallikeri in South 
Asia. Further investigations using even larger sample sizes will be required to allow for a 
differentiation of the clinical and epidemiological characteristics of the two new species.  
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Table 1: Demographic, parasitological and symptomatic profiles of PCR confirmed cases with P. 
ovale curtisi (PoC) and P. ovale wallikeri (PoW). 
Case Location 
(Upazilla) 
Age 
(years) 
sex
 
b
 
Microscopy 
a
 
Parasite 
density 
Parasites/µl 
(micros-
copy) 
Temperature 
°C 
Symptoms 
Po1W Naikhongchari 4 F Pv 2240 36.4 dizziness, fatigue, nausea, vomiting, 
runny nose, cough 
Po2W Bandarban 12 F Pm 6680 38.9 chills, headache, myalgia, dizziness, 
fatigue, abdominal pain, nausea, 
runny nose 
Po3W Bandarban 12 F Pm 2600 36.3 chills, headache, myalgia, dizziness, 
fatigue, abdominal pain, arthralgia 
Po5W Rowangchari 38 M Pv 120 36.9 asymptomatic 
Po6W Lama 10 M Pf 560 37.0 asymptomatic 
Po7W Naikhongchari 49 M Pv 440 <36.5 asymptomatic 
Po8W Alikadom 17 M Pv 320 36.5 asymptomatic 
Po9W Alikadom 5 F Pf 14520 36.8 asymptomatic 
Po11W Ruma 53 F negative - 36.5 asymptomatic 
Po13W Naikhongchari 4 F Pv 1120 <36.5 asymptomatic 
Po19W Rowangchari 24 F negative - <36.5 asymptomatic 
Po21W Ruma 47 M negative - <36.5 asymptomatic 
Po22CW Ruma 16 F negative - 36.7 asymptomatic 
Po4C Bandarban 30 M Pv 280 37.5 chills, headache, dizziness, fatigue, 
vomiting 
Po10C Ruma 5 F Pf + Pv 160 + 320 <36.5 asymptomatic 
Po12C Thanchi 38 M negative - 35.9 asymptomatic 
Po14C Naikhongchari 22 F negative - 36.7 asymptomatic 
Po15C Bandarban 59 M negative - <36.5 asymptomatic 
Po16C Rowangchari 38 M negative - <36.5 asymptomatic 
Po17C Rowangchari 35 M Pf 3080 <36.5 asymptomatic 
Po18C Rowangchari 9 M negative - 36.9 asymptomatic 
Po20C Ruma 26 M negative - <36.5 asymptomatic 
Po23C Rowangchari 19 F negative - <36.5 asymptomatic 
a Pf = P. falciparum; Pv = P. vivax; Pm = P. malariae;  b M = male; F = Female 
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Table 2: Summary of the PCR results, Genotype analysis and GenBank Accession Num-
bers for all P. ovale isolates examined in this study. (PoC = P. o. curtisi; PoW = P. o. wal-
likeri; Pf = P. falciparum; Pv = P. vivax; Pm = P. malariae; nd = not done) 
 PCR results a 
Genotype Sequence 
Analysis 
GenBank Accession Numbers 
Case PoR PoC PoV PoTRA 
including other 
Plasmodium sp. 
SSU 
rRNA 
Porbp2 Cox1 
SSU 
rRNA 
Porbp2 Cox1 
Po1 +  + PoW PoW PoW PoW PoW JF894407 JF894422 JF894419 
Po2 +  + PoW PoW PoW PoW PoW JF894406 JF894423 JF894416 
Po3 +  + PoW PoW PoW PoW PoW JF894408 JF894424 JF894417 
Po4 + +  PoC PoC PoC PoC PoC JF894403 JF894427 JF894412 
Po5 +  + PoW PoW PoW PoW PoW JF894409 JF894425 JF894418 
Po6 
  + nd Pf + PoW 
Po7 +  + nd Pf + PoW 
Po8 +  + nd Pf + Pm + PoW 
Po9 +  + nd Pf + PoW 
Po10 + +  nd Pf + Pv + PoC 
mixed infections 
Po11 +  + PoW PoW PoW nd PoW JF894411 nd JF894420 
Po12 + +  PoC PoC nd nd PoC nd nd JF894413 
Po13 
  + PoW PoW PoW PoW PoW JF894410 JF894426 JF894421 
Po14 + +  PoC PoC PoC PoC PoC JF894405 JF894428 JF894414 
Po15 + +  PoC PoC PoC PoC PoC JF894404 JF894429 JF894415 
Po16 
 +  nd Pf + PoC 
Po17 + +  nd Pf + Pm + PoC 
Po18 + +  nd Pf + PoC 
Po19 +  + nd Pf + PoW 
Po20 + +  nd 
Pf + Pv + Pm + 
PoC 
Po21 
  + nd 
Pf + Pv + Pm + 
PoW 
mixed infections 
 95 
Po22 + + + nd 
Pf + Pv + Pm + 
PoC + PoW 
Po23 + +  nd Pv + PoC 
a
 PoR = rOVA1-rPLU2 (NP-2002), PoC = rOVA1-rOVA2 (NP-1993), PoV = rOVA1v-rOVA2v (NP-2005)  
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Table 3: Dimorphic characters in cox1 nucleotide sequences among 10 P. ovale isolates 
from Bangladesh (P. ovale curtisi and wallikeri) in comparison with published isolates of 
P. ovale in human and chimpanzee hosts (FJ40569-FJ409571). 
 
Sequences 249 257 449 458 462 473 575 632 657 830 966 1082 
Plasmodium 
ovale curtisi 
(n=6) 
C C T T C C T G C C A T 
Plasmodium 
ovale wallikeri 
(n=4) 
T A C C T T G A T T G A 
P. ovale classical 
type 
(FJ409571) 
  T T C C T G C C A T 
P. ovale variant 
type (FJ409570) 
  C C T T G A T T G A 
P. ovale variant 
type chimpanzee 
(FJ409569) 
  C C T T G A T T G A 
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Table 4: Dimorphic characterization in porbp2 and ssrRNA nucleotide sequences among 
P. ovale isolates from Bangladesh.  
 
Gene 
Nucleotide poly-
morphisms 
Plasmodium ovale 
curtisi 
Plasmodium ovale 
wallikeri 
porbp2a 39, 85, 121, 145, 193, 
249, 294, 310, 323, 
375, 431, 459, 516, 
538, 561, 563, 581, 
602, 628, 741, 745 
T.T.G.C.T.A.A.C. 
A.T.A.T.A.T.A. 
A.T.A.T.T.A 
C.G.A.T.G.G.G.T. 
G.G.T.C.G.A.G. 
G.C.G.G.G.T 
ssrRNA b 201, 202, 205, 206, 
207, 234, 236, 244, 
284, 287, 675, 682, 
684, 697, 714, 731, 
775, 779, (782-784), 
787, 789, 793, 901, 
918 
A.T.C.C.G.A.G. 
T.G.G.A.C.A.A. 
T.G.T.G. (TAT) T. 
A.T.G.C 
T.G.T.T.A.G.A. 
C.T.A.G.G.T.G. 
C.C.C.A. (---) C. 
T.C.A.T. 
a
 Two samples (Po2 and Po3) classified as P. ovale wallikeri varied in following position: 293 – A instead of 
G  
b Three samples classified as P. ovale wallikeri – Po2, Po3, Po13 – shared residues 684 with P. ovale curtisi. 
Furthermore Po13 shared residues 202 with the classic type. 
 98 
Figure 1: 
Plate 1: Summary of Plasmodium ovale cases in Bandarban District (PoW = P. o. wal-
likeri, PoC = P. o. curtisi) 
Plate 2: Summary of mono- and mixed infections of P. o. curtisi and P. o. wallikeri (Pf = 
P. falciparum, Pv = P. vivax, Pm = P. malariae) 
Plate 3: Visualization of the sympatric distribution of  P. o. curtisi and P. o. wallikeri in 
Bandarban District 
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Figure 2:  
Bayesian phylogenetic tree inferred from SSU rRNA sequences of Sutherland et al. (2010), 
and of samples of P. ovale wallikeri and P. ovale curtisi collected in Bangladesh. P. gon-
deri was used as outgroup. Bayesian posterior probabilities are given left of the slash, re-
spectively bootstrap values of a Neighbor-Joining analyses right of the slash. 
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6.5 Molecular epidemiology of Plasmodium malariae and P. knowlesi in 
Bangladesh. 
 
6.5.1 Introduction 
Although malaria is known to be hypoendemic in the South-Eastern part of Bangladesh, 
there is scarce information about 4 of the 6 Plasmodium species parasitizing humans (Khan 
2011). Beside the two newly described P. ovale species, P. ovale wallikeri and P. ovale 
curtisi, there is also a lack of knowledge about the distribution of P. knowlesi and P. ma-
lariae in Bangladesh.  
 
P. malariae is known to be endemic in all major malaria endemic areas in the world. This 
parasite is widespread throughout sub-Saharan Africa, Southeast Asia, the Western Pacific 
Islands and in many areas of the Amazon Basin of South America (reviewed in Mueller et 
al. 2007). The prevalence of P. malariae has a range from less than 4% to more than 20%, 
but recent molecular epidemiological studies suggest that the true burden of infections with 
P. malariae is vastly underestimated. In Bangladesh the first published report of this 
pathogen was filed in 2004, where a prevalence of 1% was determined in a study con-
ducted in the Chittagong Hill Tracts (van den Broek et al. 2004). Furthermore, one case of 
an extremely rare and severe P. malariae infection was documented in 2010 (Rahman 
2010).  
 
P. knowlesi was formerly known as a simian parasite occurring in macaques only, but in 
recent years several human cases of infections with this pathogen were reported until it was 
recognized as the fifth human malaria species (White 2008). This parasite is known to be 
endemic in several Southeast Asian countries only (Kantele 2011). The distribution of this 
parasite is strictly limited to its intermediate hosts (several macaque species with Macaca 
fascicularis as the main host) and its final hosts (mosquitos of the Anopheles leucosphyrus-
group) (Cox Singh et al. 2008a, Sallum et al. 2005). In Bangladesh the final host as well as 
the intermediate host are present, although the population of Macaca fascicularis is limited 
to the Southeasternmost part of Bangladesh (Molur 2003). 
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Within this chapter unpublished data of the distribution of P. malariae and P. knowlesi and 
the phylogenetic analysis of P. malariae obtained within a hospital-based fever study and a 
cross-sectional field survey will be summarized (Fuehrer 2010, Fuehrer 2011a).  
 
6.5.2 Materials and Methods 
Blood spots on filter papers were collected from 379 patients presenting febrile diseases 
and 1867 asymptomatic participants as mentioned in chapter xx (Fuehrer 2011a). A nested 
PCR binding at conserved regions of the mitochondrial SSU rRNA gene was used for the 
screening of P. malariae and P. knowlesi. These techniques were mentioned and/or sum-
marized in previous chapters. The species specific primer-pairs rMAL1 and rMAL2 and 
Pmk8 and Pmk9r were used for the detection of P. malariae and P. knowlesi respectively.  
For the diagnosis of variations of P. malariae five positive samples were further analyzed 
by partial sequence analysis of the SSU rRNA gene. Therefore, five blood samples with P. 
malariae monoinfections were analyzed with the genus-specific primers rPLU2 and rPLU3 
and sequenced. The sequences were analyzed as previously described (Fuehrer 2011a). 
 
6.5.3 Results  
In asymptomatic participants we found an overall prevalence of P. malariae of 2.8%, and 
9.6% of those were positive for any kind of malaria. In total 53 participants of the asymp-
tomatic survey and 7 of the fever study were tested positive for P. malariae by PCR analy-
sis. The rate of mixed infections was high (Fig. 1 and 2). 
We found no evidence for the presence of P. knowlesi in those studies. 
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Pm + Pf + Pv + PoV
Pm + Pf + Pv + PoC + PoV
      
Fig. 1: Comparison of mono- and mixed infections of P. malariae in Bangladesh (Pf = P. falciparum, Pv = 
P. vivax, Pm = P. malariae, PoV = P. ovale (variant form), PoC = P. ovale (classic form) 
 
Partial sequence analysis of the SSU rRNA gene of 5 isolates of P. malariae revealed 5 
almost identical partial sequences. These sequences were identical (or at least 99%) to a P. 
malariae isolate collected in a chimpanzee (GenBank Accession Number: AB489195) 
(Hayakawa et al. 2009).  
 
6.5.4 Discussion 
Although P. knowlesi was not present in any of the samples examined within this study, 
the possible distribution of this pathogen in Southeastern Bangladesh should be kept in 
mind. Human infections with this parasite are often mistaken in microscopy-based diagno-
sis for infections with P. falciparum (early trophozoites) or P. malariae (similar morphol-
ogy) (Singh et al. 2004, Lee et al. 2009). P. knowlesi has a daily (quotidian) life cycle, po-
tentially leading to a fatal outcome. Fatal cases have been documented in Malaysia (Cox-
Singh et al. 2008b). Hepatorenal dysfunction and hyperparasitemia were reported. How-
ever, the nominal distribution of the main intermediate host (Macaca fascicularis) to the 
very Southeastern parts of Bangladesh may be the factor of limitation for the probable ab-
sence of P. knowlesi in Bangladesh. Due to the fact that this malaria-causing parasite and 
Macaca fascicularis are endemic in nearby Myanmar, and the presence of migration of 
refugees from Myanmar to Bangladesh, microscopists in Bangladesh should be aware of 
this to prevent mix-ups with other malaria pathogens (Jiang et al. 2010).  
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P. malariae possesses a quartan life cycle and its clinical symptoms are known to be less 
harmful if compared to P. falciparum. It is known for its long living blood stage parasites 
causing recrudescences (Collins and Jeffery 2007). P. malariae is responsible for 1-2% of 
all fever cases in malaria endemic countries and causes up to 50% of all malaria cases in 
the low-transmission season in areas with seasonal distribution (Mueller et al. 2007). Most 
epidemiological studies in the past were based on the diagnosis by light microscopy only. 
However, the microscopical differentiation between P. malariae and P. falciparum is diffi-
cult, and in areas where P. falciparum is dominant the true prevalence of P. malariae 
might be mistaken (Mueller et al. 2007). The introduction of molecular diagnostic tools 
simplifies the accurate diagnosis of parasites like P. malariae.  
In our study 3.9% of the fever patients presenting with malaria were positive for P. ma-
lariae. The prevalence of P. malariae in asymptomatic malaria positive participants was 
high with 9.6%. Neighbouring Myanmar is known to be one of the countries with the high-
est prevalence of P. malariae outside Africa, and prevalences between 10 and 20% have 
been reported in the past (Zhou et al. 1998, Garnham 1966, Haworth 1988). The zoonotic 
potential of diverse human malaria parasites is an upcoming topic of research. Several au-
thors reported human malaria parasites in monkeys. In 2009 P. malariae was found by 
analysis of the SSU rRNA gene in a chimpanzee from Africa imported to Japan (Haya-
kawa et al. 2009). Furthermore, P. malariae is genetically indistinguishable from P. bra-
silianum, a parasite of platyrrhine new-world monkeys. Recent studies revealed identical 
sequences within the Csp-, SSU rRNA-, and MSP-1 genes and brought up discussions of 
the host transfer from human to monkeys or vice versa (Escalante et al. 1995, Tazi et al. 
2011).  
Within this study 5 partially sequenced SSU rRNA genes of P. malariae gave almost iden-
tical results. However, sequence variations within the SSU rRNA gene are known from 
China to Southeastern Asia (Liu et al. 1998). We estimate that different forms of P. ma-
lariae might be present in Southeastern Bangladesh, but limited financial resources al-
lowed the sequence analysis of a few samples only.   
Within our study 53 participants were positive for P. malariae without showing any kind 
of symptoms. Such results make it obvious that there is an urgent need for further studies 
to examine not only the epidemiology, but also the clinical features of P. malariae monoin-
fections and mixed infections in Bangladesh. 
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6.6  A highly sensitive in vitro-assay for the detection and quantifica-
tion of Plasmodium vivax parasite biomass after the usage of dif-
ferent cultivation methods. 
 
6.6.1 Introduction 
Plasmodium vivax is the most widely distributed and, with the exception of equatorial Af-
rica, the most prevalent causative of malaria infections in humans (Mendis et al. 2001). 
Annually up to 70 million cases of infections with P. vivax are reported from endemic 
countries from Asia, Africa, Central and South America, Oceania, the Middle East and 
some countries in Europe. Although the mortality rate of P. vivax malaria is lower than the 
one of P. falciparum, this parasite is one of the main factors of socio-economic instability 
and poverty in affected countries. In comparison to infections with P. falciparum the ther-
apy is considerably more complex, because beside its blood forms it can form dormant 
stages in the liver. First cases of resistances to chloroquine, the drug of choice in the ther-
apy of P. vivax, were reported from Papua New Guinea in 1989 (Rieckmann et al. 1989, 
Schuurkamp et al. 1989). Further Asian countries (e.g. India and Myanmar) reported 
chloroquine resistances in the upcoming years (WHO 2010). Furthermore, antifolate-
resistances of P. vivax were documented frequently in Southeast Asia and less commonly 
in South Asia (WHO 2007). This leads to the urgent need to establish in vitro cultivation 
techniques to expedite and facilitate the development of drugs against P. vivax (Wernsdor-
fer et al. 2008). 
However, the in-vitro cultivation of P. vivax is confronted with a number of problems and 
several researchers tried to cultivate this parasite before the 1980s without success (Udom-
sangpetch et al. 2007). Long-term cultivation of these pathogens require the supplementa-
tion and modification of standard culture media (e.g. RPMI) and the addition of reticulo-
cytes obtained from normal or hemochromatoic blood (WHO 2007, Udomsangpetch et al. 
2007). In the peripheral blood circulation parasitemias of P. vivax are generally low be-
cause of the low proportion of reticulocytes (Geaghan 2000). Furthermore, for cultivation 
only parasite isolates with a predominance of ring forms should be taken (WHO 2007). 
This circumstance led to the fact that up to now no cultivation technique was employed 
which allows the cultivation of P. vivax under field conditions for 72 hours (e.g. Druilhe et 
al. 2007). 
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6.6.2 Materials and Methods 
The study was part of a hospital based fever survey which was conducted from 2008 to 
2009 at the MARIB field site (Bandarban Sadar Hospital, Bangladesh). From each patient 
or their legal representatives’ written informed consent was obtained before blood collec-
tion. The study protocol was reviewed and approved by the Ethical Review Committee of 
the International Center of for Diarrhoeal Diseases Research, Bangladesh. Heparinized 
blood samples were collected from patients with microscopically confirmed P. vivax 
monoinfections with a parasitemia of 0.5% or higher. Those samples were cultured on 96-
well microtiter plates for 72 hours at 37°C, 5% C, 5% O2 and 90% N2 with different tech-
niques to optimize growth.  
First, various kinds of standard media were prepared (e.g. RPMI 1640, McCoy 5A) and 
supplements (e.g. vitamines, hypoxanthine, ascorbic acid) were added to those media in 
concentrations mentioned by various authors (Tab. 1, Fig. 1). Subsequently tests on the 
effect of media changes (no change, change every 24 hours, change every 48 hours), the 
effect of leukocyte filtration, addition of cord blood (retikulocytes), and the influence of 
different serum concentrations (15-50%) were made.  
 
Table 1: Supplements used for the cultivation of P. vivax. 
Supplements used Concentrations 
Ascorbic acid 2.84 – 34.1 µM 
Dextrose 5.55 – 16.65 mM 
Hypoxanthine  73.74 – 370 µM 
Thiamine hydrochloride 8.8 µM 
Potassium dihydrogene phosphate 120 µM 
Calcium chloride 270 µM 
Magnesium sulfate 130 µM 
HEPES 25 mM 
Vitamin B complex 10 µM 
 
In the last trials one cultivation technique with a proven reinvasion of P. vivax was chosen 
to examine the influence of hypoxanthine (no addition, 73 µM, 370 µM, 1,000 µM) on the 
growth of P. vivax and P. falciparum. 
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For the microscopical anlaysis of the parasitemia culture slides (thin smear and thick drop) 
were made 0, 24, 48 and 72 hours after starting the culture. Parasites were differentiated 
into growth stages – ring forms, trophozoites and schizonts – as reported previously 
(Chotivanich et al. 2001). Furthermore, cultured parasite samples were transferred from the 
culture plate to a second microtiter plate 0, 24, 48 and 72 hours after starting cultivation. A 
highly sensitive aldolase-double site sandwich ELISA was performed using two polyclonal 
antialdolase antibodies (RPVA-55A and RPVA-55P, Immunology Consultants Laborato-
ries, Newberg, OR, USA) to detect and quantify aldolase which is produced by all para-
sites of the genus Plasmodium. 
 
Fig. 1: Udomsangpetch R et al. (2008): Cultivation of Plasmodium vivax. Trends Parasitol. 2008 
Feb;24(2):85-8. 
 
 
Fig. 2: Chotivanich K et al (2001).: Ex-vivo short-term culture and developmental assessment of Plasmodium 
vivax. Trans R Soc Trop Med Hyg. 2001 Nov-Dec;95(6):677-80 
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6.6.3 Results and Conclusions  
Overall 98 different cultivation techniques were tested with up to 6 different P. vivax field 
isolates to optimize growth of P. vivax in in vitro culture under field conditions. The addi-
tion of supplements (especially ascorbic acid, hypoxanthine, and dextrose) enables an op-
timized growth for 24 hours with microscopically confirmed reinvasion (Fig. 3). Best para-
site growth was obtained with the supplementation according to Chotivanich (2001) con-
sisting of 1 g dextrose, 16 mg MgSO4, 26 mg KH2PO4, 30 mg CaCl2, 6 mg ascorbic acid, 3 
mg thiamine and 10 mg hypoxanthine to each 1,000 ml of RPMI-1640 medium.  
 
 
Fig. 3: Cultivation of P. vivax with supplemented RPMI-1640 media and 50% serum under field conditions 
in Bangladesh. 
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Furthermore, the influence of serum concentrations on parasite growth was confirmed. 
Within the same media a two-fold increase in growth rate was shown with the use of serum 
concentrations between 30 and 50% in contrast to serum concentrations between 20 and 
25% (Fig. 4). 
 
Fig. 4: Influence of serum concentrations on the growth of P. vivax at cultivation under field site conditions 
for 0, 24, 48 and 72 hours (ordinate = ODs 0-3.5 using an ELISA plate reader at 450 nm). 
 
The change of media and leukocyte filtration tests had almost no effects on parasite growth 
under field site conditions. Furthermore, cultivation of P. falciparum in media supple-
mented with hypoxanthine (73 µM and 370 µM), dextrose and ascorbic acid leads to a 3-5 
fold increase of the growth rate in comparison to the cultivation with common hypoxan-
thine-free RPMI-1640 medium.  
 
The aldolase-ELISA used in this study has proven to be highly sensitive and well suited for 
quantifying parasite growth and its inhibition. The limit of detection of ELISA reaches 
0.0005% of infected red blood cells and is considerably more sensitive in P. vivax than in 
P. falciparum (Thriemer et al. 2008). 
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In 72 h P. vivax cultures optimal growth rates and conditions continue to be a problem. The 
number of samples that actually grow and lead to reinvasion remains small. A short-time 
cultivation of P. vivax for 24 hours with proven reinvasion was confirmed, but after 24 
hours parasitemia is declining. Our results hereby confirm those published by the group 
around Chotivanich in 2001 (Fig 2, Fig 3). However, none of the tested techniques is suit-
able to reach a growth needed for a 72 hour cultivation technique used at drug activitiy and 
drug resistance tests at P. falciparum. We assume that the main causative is the preference 
of P. vivax for reticulocytes, and tests where highly equipped laboratories are needed 
turned out not to be suitable for the usage under field site conditions.  
There is an urgent need to optimize growth conditions for P. vivax to obtain dose-response 
curves similar to those achieved with the HRP2 drug sensitivity assay standardized for P. 
falciparum.  
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7 Conclusion 
 
Optimized standards in the diagnosis of Plasmodium species are essential to control and 
adequately treat malaria. Although the limitations of microscopy are known, it still remains 
the gold standard of malaria diagnosis. Lower sensitivity of microscopy may lead to a vast 
underestimation of the true malaria burden, especially of less documented species such as 
P. malariae, P. ovale, and P. knowlesi in South and South-East Asia. 
 
Until very recently only P. falciparum and P. vivax were known to be endemic in Bangla-
desh. Most malaria studies had their focus on these parasites only, because these malaria 
species are the main causatives of symptomatic malaria (e.g. Thriemer et al. 2006; Star-
zengruber et al. 2009). Less than a handful of cross-sectional malaria surveys were per-
formed in Bangladesh and those were based on the diagnosis by RDTs or microscopy only 
(Haque et al. 2009; Maude et al. 2008).  It took until 2004 before P. malariae was first 
reported, with a prevalence of 1% in patients from the Chittagong Hill Tracts, and since 
this report only one case of a severe infection with P. malariae has been published (van der 
Broek et al. 2004, Rahman et al. 2010). Neither P. ovale nor P. knowlesi were considered 
to be endemic in Bangladesh.  
 
In our initial study we were the first in the region who analyzed blood samples collected in 
a hospital-based fever survey by nested PCR-corrected microscopy not only to examine the 
prevalence of P. falciparum, P. vivax, and P. malariae in febrile patients, but with the main 
purpose of evaluating the endemicity of P. ovale and P. knowlesi in the Chittagong Hill 
Tracts. 379 blood samples on filter papers of patients reporting fever within the last 72 
hours were analyzed by standardized nested PCR techniques targeting highly conserved 
regions of the SSU rRNA gene (e.g. Snounou and Singh 2002). In total 189 out of 379 
(49.9%) febrile participants tested positive for Plasmodium sp. at genus-specific Nest 2 
PCR. Although P. falciparum (81.5%) and P. vivax (26.5%) were the dominant species in 
the district of Bandarban, 3.7% of all patient samples gave positive results for P. malariae 
and 1.6% for P. ovale. The rate of mixed infections was high at 13.2%. P. knowlesi was 
not found in any of the analyzed samples.  
 
A second survey conducted in our field site in Bangladesh focused on analyzed blood sam-
ples of asymptomatic participants within a cross-sectional survey in the District of Bandar-
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ban (Habler et al. 2010). Within this study an asymptomatic malaria prevalence of 22.3% 
was observed. P. falciparum was the dominant species, causing 80.2% of all infections, 
followed by P. vivax (32.4%), P. malariae (9.6%), and P. ovale (3.44%). 
 
The true malaria burden, especially of the less common malaria parasites and mixed infec-
tions, was grossly underestimated before. Our initial results gave a fair warning that mo-
lecular tools are not only of higher sensitivity and specificity than microscopy, but also 
uncover a higher malaria prevalence and number of mixed infections compared to non-
PCR-based studies (Steenkeste et al. 2009). 
 
Within the first PCR-corrected study we were able to detect for the first time in Bangla-
desh P. ovale in three (1.6%) patients, who presented febrile, malaria-like symptoms at our 
MARIB field clinic. The parasites were misdiagnosed by microscopy as P. malariae or P. 
vivax because P. ovale was not known to be endemic in this region. Moreover, we were 
able to diagnose the first confirmed case of a relapse caused by this pathogen in Bangla-
desh, which was further described within a case report by our team (Starzengruber et al. 
2010).  
Because of the use of the primer pair rPLU2/rOVA1 (a genus-specific primer combined 
with a classic P. ovale specific primer), we decided to sequence these three samples and 
found that two of these isolates were of the variant type and one of the classic P. ovale 
type, thus leading to the suggestion that both the classic and the variant type of P. ovale are 
present and occur sympatrically in the Chittagong Hill Tracts. As described in the introduc-
tion to this thesis, the diagnosis of P. ovale by standard nested PCR protocols is problem-
atic (Snounou et al. 1993; Snounou and Singh 2002).  
Within the second study we tested all three primer pairs binding in the mitochondrial SSU 
rRNA gene (rOVA1/2; rOVA1/rPLU2; rOVA1var/rOVA2var) in more than 2,200 blood 
samples of febrile and asymptomatic participants and sequenced those samples presenting 
monoinfections of P. ovale only. Furthermore, the cox1 gene, which was documented as 
suitable in the differentiation between variant and classic P. ovale parasites, was analyzed 
after sequencing. However, while the second study was running, the group around Collin 
Sutherland divided P. ovale into the species P. ovale curtisi (classic type) and P. ovale 
wallikeri (variant type) because of their dimorphic genetic characteristics in several gene 
loci. Sympatric distribution from Africa of those pathogens was described. Although sam-
ples from Asia (e.g. Thailand) were used in this study, only variant P. ovale wallikeri para-
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sites were reported (Sutherland et al. 2010). Some previous observations of variations in P. 
ovale in South-East Asia (Myanmar and Thailand) were mentioned (Zhou et al. 1998, Win 
et al. 2002; Win et al. 2004), but as yet no prevalence study has dealt with the differentia-
tion of both species in Asia.  
Within our second study we further performed a nested PCR technique within the potra 
gene to discriminate the two new species and analyzed sequences of the Porbp2 gene, as 
described by the group around Sutherland (Sutherland et al. 2010; Oguike et al. 2010). We 
detected P. ovale in 2.12% of Plasmodium sp. positive patients presenting febrile illnesses 
(P. ovale wallikeri: 1.59%; P. o. curtisi 0.53%) and in 3.44% of all asymptomatic malaria-
positive participants (P. ovale wallikeri and P. o. curtisi 1.63% each, plus one patient pre-
senting both pathogens) by nested PCRs of the SSU rRNA gene and the potra gene.  
 
Within this study we were able to prove the sympatric distribution of P. ovale wallikeri and 
P. ovale curtisi in South Asia for the first time. Furthermore, this is the first analysis of 
those sympatric distributions within an area of less than 5,000 km2 worldwide. Phyloge-
netic analysis within partial sequences of the SSU rRNA, Porbp2, and Cox1 genes of blood 
samples presenting monoinfections with these pathogens confirmed that P. ovale wallikeri 
and P. ovale curtisi are two distinct species.  
Nested PCR analysis within the potra gene is recommendable for the differentiation of 
both species. For the standard nested PCR binding within conserved regions of the SSU 
rRNA, two primer pairs (= two different PCRs) should be used for the diagnosis of P. 
ovale, namely rOVA1/rOVA2 for P. ovale curtisi (classic type) and rOVA1var/rOVA2var 
for P. ovale wallikeri (variant type). 
Only mild ovale malaria symptoms like moderate fever, chills, headache, and fatigue were 
observed in febrile patients. However, most infections with P. ovale were asymptomatic in 
this study. Parasite densities in monoinfections were low at 120–6,680 parasites/µl. Further 
clinical, epidemiological, and phylogenetic analysis is needed to determine differences 
between P. ovale wallikeri and P. ovale curtisi.  
 
Although P. malariae was first described in the Chittagong Hill Tracts in 2004 and a se-
vere Plasmodium malariae case was reported from Chittagong, information about this 
parasite is lacking in Bangladesh (van der Broek 2004, Rahman 2010). Overall, 60 patients 
presented P. malariae infections and over 50% of those were mixed infections with other 
human malaria parasites. Within our studies we examined a prevalence of P. malariae in 
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1.8% of the febrile patients and in 2.8% of the asymptomatic volunteers. The slightly 
higher prevalence of P. malariae in asymptomatic participants can be explained by typi-
cally milder clinical manifestations compared to other malaria parasite species, and by the 
circumstance that this parasite can inhabit its human host for an extended period of time. 
The prevalence in South-East Asia is normally below 4% (Mueller et al. 2007). However, 
neighboring Myanmar is known to be one of the countries with the highest prevalence of 
P. malariae outside Africa, and a prevalence of between 10 and 20% has been reported in 
the past (Zhou et al. 1998, Garnham 1966, Haworth 1988). Within this study five partially 
sequenced SSU rRNA genes of P. malariae gave almost identical results. However, se-
quence variations within the SSU rRNA gene are known from China to South-Eastern Asia 
(Liu et al. 1998). We estimate that different forms of P. malariae might be present in 
South-Eastern Bangladesh, but limited financial resources allowed the sequence analysis of 
a few samples only.  
Overall, our results confirm the presence of P. malariae in the Chittagong Hill Tracts with 
a prevalence of almost 10% in malaria-positive asymptomatic patients. Although P. ma-
lariae is known to be less severe than P. falciparum, care should be taken by practitioners 
to prevent misdiagnosis.   
 
P. knowlesi, a simian malaria parasite, is now recognized as a species frequently infecting 
humans in several South-East Asian countries (White 2008). Analysis was performed 
within the SSU rRNA gene using the primers Pmk8 and Pmk9r. Cross-reactivity of these 
primers with P. vivax genomic DNA within the ssr RNA-S gene was reported previously 
and was also confirmed within our study by sequence analysis (Imwong et al. 2009). How-
ever, although these primers bind to P. vivax, they can be used for the detection of P. 
knowlesi. The amplified sequences only vary minimally in size and can be differentiated 
with the use of a positive control and, if a large gel is used, for analysis during gel electro-
phoresis. We observed no case of P. knowlesi in any of the samples collected in the Chit-
tagong Hill Tracts. Both natural hosts – Macaca fascicularis as well as mosquitoes of the 
Anopheles leucosphyrus group are reported to be endemic in South-Eastern Bangladesh, 
but the distribution of M. fascicularis is limited to the very south-eastern part of the Chit-
tagong Hill Tracts only (Molur et al. 2003). Furthermore, several tribes of the indigenous 
population hunt monkeys as game, and so the distribution might be scarce. This may have 
caused the absence of P. knowlesi within the studies performed. However, because of the 
morphological similarities to P. falciparum (young rings) and P. malariae (other blood 
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stages), care should be taken to prevent misdiagnosis, not only in epidemiological surveys 
and local laboratories, but also in the diagnosis of travellers returning from South-East 
Asia presenting malaria (Lee et al. 2009).   
 
Microscopy and RDTs are the most commonly used diagnostic tools of malaria, and mi-
croscopy still remains the gold standard for malaria diagnosis. The limits of detection vary 
between microscopists and are estimated to range between 50 and 100 parasites/µl 
(Wongsrichanalai et al. 2007). The introduction of molecular techniques in recent decades 
allows a far more sensitive method of detection of these pathogens. Within the third study 
a novel nested Direct PCR technique was established which allows PCR amplifications 
without prior DNA purification or isolation steps using a Phusion blood polymerase. The 
biggest advantage of Direct PCR is the saving of time, because the complete step of DNA 
isolation and purification is not needed. Furthermore, specificity (96%) and sensitivity 
(99.8%) are very high and comparable to previous protocols used in malaria diagnosis (e.g. 
Snounou and Singh 2002). Moreover, the limit of detection is only 3 parasites/µl compared 
to 6 parasites/µl with standard techniques (Singh et al. 1999). Furthermore, Direct PCR is a 
useful alternative to common PCR protocols, providing a highly sensitive, rapid, and cost-
effective method of malaria and other blood pathogen diagnosis. Within our molecular 
epidemiological studies we used Direct Nested PCR with those samples showing poor 
positive signals at standard nested PCR (because of low parasitemia) to obtain more evalu-
able DNA after a Nest 1 reaction for sequence PCRs and sequence analysis. 
 
P. vivax is considered to be the most prevalent and most widely distributed malaria parasite 
in humans worldwide. However, drug sensitivity tests are hampered by the inability to cul-
ture this malaria parasite for at least 72 hours with continuous growth. P. vivax has – like 
P. ovale – the preference to invade reticulocytes, but only 1–2% of the red blood cells are 
of this type in healthy individuals (Kasper et al. 2005). Thus the preference for reticulo-
cytes seems to be the most hampering and aggravating problem in the prolonging cultiva-
tion of P. vivax. 
Following previous published methods we tried to cultivate P. vivax parasites for 72 hours 
under field site conditions. In this experiment, 98 different cultivation techniques were 
tested. Of all techniques tested, best growth and proven reinvasion was obtained with the 
supplementation of dextrose (5.55 mM), MgSO4 (0.13 mM), KH2PO4 (0.12 mM), CaCl2 
(0.27 mM), ascorbic acid (34.1 µM), thiamine (10 µM), and hypoxanthine (73.47 µM) to 
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RPMI-1640 medium. However, although parasites can be cultivated for 72 hours the para-
sitemia starts to decline after the first reinvasion, an effect also documented by Chotivanich 
et al. (2001). We assume that the preference to invade reticulocytes causes this phenome-
non. Furthermore, the addition of serum seems to play an important role in cultivating this 
parasite. We obtained twice-fold growth rates at serum concentrations of 30–50% serum in 
comparison to 20–25% serum. Overall, we can not recommend any of the tested P. vivax 
cultivation techniques for the usage in drug sensitivity assays under field site conditions, 
because the decline in parasite densities may cause misinterpretations regarding drug ac-
tivities in P. vivax. Further studies are of urgent need to optimize and simplify growth con-
ditions in P. vivax, but also in P. ovale and P. malariae.  
 
The results of this thesis can be summarized as follows: 
 
1. P. ovale was detected in Bangladesh for the first time. 
2. Confirmation that P. ovale possesses dimorphic characteristics and consists of two 
species, namely P. ovale curtisi and P. ovale wallikeri.  
3. Both are endemic and occur sympatrically in the Chittagong Hill Tracts in Bangla-
desh. 
4. The sympatric distribution of both P. ovale curtisi and P. ovale wallikeri was 
proven in South Asia for the first time. 
5. Infections of both types of ovale malaria cause mild syndrome complexes or are 
asymptomatic. 
6. P. malariae is a common parasite in the Chittagong Hill Tracts causing mild symp-
toms or being asymptomatic. 
7. There was no evidence of P. knowlesi. 
8. P. falciparum is the dominant species causing human malaria in the Chittagong Hill 
Tracts, followed by P. vivax. 
9. A high rate of mixed infections was observed. 
10. Efforts to cultivate P. vivax for 72 hours under field conditions were of limited suc-
cess. 
11. A novel Direct PCR technique was introduced which allows a cost-effective, sensi-
tive, and rapid molecular diagnosis of malaria parasites.  
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Several years ago only four different Plasmodium species were known to infect humans 
but now six species have been confirmed as causing malaria in humans: P. falciparum, P. 
vivax, P. malariae, P. ovale curtisi, P. ovale wallikeri, and P. knowlesi (Sutherland et al. 
2010; White 2008). These verifications were only made possible by the introduction of 
molecular tools, and so enabled the confirmation of endemicity of five out of the six hu-
man malaria parasites in an area with less than 5,000 km2 in South Asia. Furthermore, our 
results confirm that the true malaria burden in the Chittagong Hill Tracts in Bangladesh 
was vastly underestimated. 
 
However, there is still an urgent need to advance (molecular) diagnostic tools to enable 
exact diagnosis of the parasites causing malaria. Progress in the cultivation of different 
Plasmodium species is also needed to allow accurate examinations to confirm resistances 
and to develop new antimalarial drugs.  
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8 Abstract 
 
Malaria infections are still one of the major global health burdens, and recent reports of 
emerging artemisinin resistance in Southeast Asia will add another challenge to malaria 
control efforts. High standards in the diagnosis of the malaria-causing Plasmodium species 
are essential in order to control and adequately treat malaria. In spite of its known limita-
tions, microscopy remains the gold standard of malaria diagnosis which may lead to a sig-
nificant underestimation of the true malaria burden, especially of less prevalent and less 
documented species such as P. ovale, P. malariae and P. knowlesi in Asia. Also the phy-
logeny of P. ovale is pending and recent studies established that P. ovale comprises 2 sym-
patric occurring non-recombining species; P. ovale curtisi and P. ovale wallikeri. 
This project aimed to detect the distribution and prevalence of P. ovale (P. o. curtisi and P. 
o. wallikeri), P. malariae and P. knowlesi in the Chittagong Hill Tracts in Bangladesh. 
Therefore 2,246 blood spots of asymptomatic and febrile participants were analyzed by 
nested PCR targeting highly conserved regions of the small subunit ribosomal RNA (SSU 
rRNA) gene. P. ovale was detected in 1.02% of the study participants; 0.45% thereof were 
infected with P. o. curtisi, 0.53% with P. o. wallikeri and 0.04% presented infections with 
both parasites. Both parasite species occur sympatric in the District of Bandarban and 
demonstrate none or mild symptoms. Furthermore dimorphism between both species was 
confirmed by different PCR techniques (e.g. comparison of different protocols targeting 
the SSU rRNA gene; PoTRA gene) and multilocus sequence analysis (SSU rRNA, Cox 1, 
PoRBP2). Not only the first description of P. ovale in Bangladesh was documented in the 
course of this thesis, but also the sympatric distribution of P. o. curtisi and P. o. wallikeri 
was confirmed in (South) Asia for the first time. 
 
A high prevalence of 9.6% of P. malariae was found in those asymptomatic patients posi-
tive for Plasmodium sp. by nested PCR. In comparison, 3.7% of those fever patients pre-
senting malaria were diagnosed as P. malariae infections. There was no evidence of P. 
knowlesi within those studies. 
 
Furthermore we demonstrated that the newly employed use of direct nested PCR enabled 
the detection of Plasmodium sp. from blood spots on filter papers without the time-
consuming use of DNA isolation and compared it to a standardized nested PCR technique. 
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Direct nested PCR is highly sensitive and the limit of detection is as low as 3 malaria para-
sites/µl.  
 
However, attempts to cultivate P. vivax under field conditions for 72 hours failed. Al-
though reinvasion was achieved with some media, none of the more than 90 cultivation 
techniques resulted in an exponential growth rate comparable to the growth of P. falcipa-
rum because of a decline of parasitemia after 48h. 
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9 Zusammenfassung 
 
Malaria-Infektionen sind auch heutzutage noch eine der größten Bürden für das Gesund-
heitssystem weltweit. Kürzlich nachgewiesene Artemisinin-Resistenzen in Südostasien 
erschweren Bemühungen der Malaria Herr zu werden. Daher sind hohe Standards in der 
Diagnose der Malariaerreger aus der Gattung Plasmodium  notwendig um Malaria zu kon-
trollieren und adäquat zu therapieren. Obwohl die Nachteile der Malariadiagnose mittels 
Mikroskopie bekannt sind, ist jene immer noch der Goldstandard, das wiederum zu einer 
Unterschätzung der wahren Malariazahlen führen kann und speziell den Nachweis weniger 
häufiger und dokumentierter Arten wie P. ovale, P. malariae und P. knowlesi in Asien 
betrifft. Die Phylogenie von P. ovale wird derzeit neu bearbeitet und eine kürzlich veröf-
fentlichte Studie teilte die ursprüngliche Art P. ovale in zwei sympatrisch vorkommende 
Arten auf: P. ovale curtisi und P. ovale wallikeri.  
Ein Hauptziel dieser Studie war die Untersuchung des Vorkommens sowie der Prävalenz 
von P. ovale (P. o. curtisi und P.o. wallikeri), sowie von P. malariae und P. knowlesi in 
den Chittagong Hill Tracts in Bangladesh. Dafür wurden 2.246 Blutproben auf Filterpapier 
von asymptomatischen, sowie febrilen Studienteilnehmern mittels einer nested PCR die an 
höchst konservierten Regionen der kleinen ribosomalen Untereinheit des SSU rRNA Gens 
bindet, untersucht. 1,02% aller Studienteilnehmer waren P. ovale positiv. Bei 0,45% konn-
te eine Infektion mit P. o. curtisi, bei 0,53% mit P. o. wallikeri, sowie bei 0,05% eine 
Mischinfektion mit beiden Arten diagnostiziert werden. Der Nachweis von sympatrischen 
Vorkommen beider Erreger konnte im Distrikt Bandarban erbracht werden, wobei die be-
troffenen Patienten keine oder milde Symptome aufwiesen. Außerdem konnte ein geneti-
scher Dimorphismus jener zwei Arten anhand verschiedener PCR-Techniken (z.B. Ver-
gleich verschiedener Protokolle mit SSU rRNA Gen als Zielsequenz; PoTRA) sowie von 
Sequenzanalysen (SSU rRNA, Cox1, PoRBP2) bestätigt werden. Im Rahmen dieser Studie 
konnte nicht nur P. ovale erstmals in Bangladesh beschrieben werden, sondern auch die 
erstmalige Beschreibung von sympatrischen Vorkommen von P. o. wallikeri und P. o. cur-
tisi in (Süd) Asien erbracht werden. 
 
Eine hohe P. malariae-prävalenz von 9,6% konnte bei asymptomatischen Patienten mit 
PCR-bestätigter Malaria nachgewiesen werden. Hingegen wurden Infektionen mit diesem 
Erreger nur in 3,7% aller Malaria-positivien Fieberpatienten gefunden. In keiner dieser 
Studien konnte P. knowlesi nachgewiesen werden. 
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Mittels einer neuen direkten nested PCR Technik wurde die Diagnose von Plasmodium sp. 
von auf Filterpapier gesammelten Blutproben ohne die zeitaufwendige Anwendung diver-
ser DNA-Isolierungstechniken etabliert und mit standardisierten nested PCR Protokollen 
verglichen. Hierbei wies die direkte PCR sowohl eine höhere Sensitivität als auch ein ge-
ringeres Parasitennachweisbarkeitsgrenze von 3 Parasiten/µl auf. 
 
Versuche P. vivax unter Feldbedingungen für 72 Stunden zu kultivieren schlugen fehl. Es 
konnte zwar bei einigen Medien eine erfolgreiche Reinvasion nachgewiesen werden, je-
doch wurde bei keinem der über 90 verschiedenen untersuchten Kultivierungstechniken ein 
mit P. falciparum vergleichbares exponentielles Wachstum beobachtet werden, da es nach 
einer Kultivierungszeit von 48 Studien zu einem Abfall der Parasitämie kam.    
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